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Abstract 
Decreased heart rate variability (HRV) seems to predict increased risks of sudden cardiac 
death. Thus HRV monitoring may provide additional information that could help in the 
risk stratification of patients. We designed a dual-channel personal computer based 
monitor to calculate HR and HRV indices, from electrocardiogram (ECG) and 
photoplethysmogram (PPG) signals. Preliminary tests showed that the PPG signal can be 
used as an alternative to obtain accurate HRV values from resting subjects.  
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1. Executive Summary 
Sudden Cardiac Death (SCD) is responsible 400,000 to 460,000 deaths per year in the 
United States [1]. Prior studies have shown that heart rate variability (HRV) analysis can 
predict mortality in recent cardiac episode survivors. This is because of the reduction in 
the body‟s ability to regulate the heart rate (HR) through the autonomic nervous system. 
Patients will present with increased HR and reduced abilities of the HR to adapt to 
changing conditions. Patient cardiac health monitoring following a severe cardiac episode 
could be beneficial as a reduced HRV, may help to risk stratify patients. HRV data is 
typically obtained through the electrocardiogram (ECG) via gel-based electrodes. 
However, this approach is problematic when used in a dynamic environment where 
subjects may be active, due to problems associated with motion artifacts. Motion artifacts 
may be especially problematic when due to signal corruption from electromyogram 
(EMG) signals. Alternatively, HRV data may be obtained from a photoplythesmogram 
(PPG) signal. The PPG signal represents varying levels of light absorption due to 
pulsations of the arteries and arterioles caused by blood pressure changes during the heart 
cycle.  
 
The goals of the project are to obtain both ECG and PPG signals for HRV calculations 
and to compensate for the problems associated with each signal analysis. For the PPG 
signal, this involves a reduction in motion artifacts as well as optimizing device battery 
life. For the ECG signal, dry electrodes must be shown to work as effectively as gel-
based electrodes in a dynamic environment. Data obtained from ECG and PPG signals 
must be closely correlated to show the PPG signal as an effective alternative to help 
prevent problems associated with ECG signal acquisition.  
 
Optimizing battery life of the PPG unit was done by reducing the power requirements of 
the PPG photodetection unit. To minimize the affects of motion artifacts within the PPG 
signal, areas of the body were analyzed to determine the portion least susceptible to 
motion artifacts. Problems associated with gel-based ECG electrodes were attenuated 
through implementation of dry electrodes. Signals obtained via dry electrodes were used 
to determine whether dry electrodes offer an effective alternative to gel-based electrodes. 
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ECG and PPG signals were recorded and analyzed simultaneously under rest and motion 
artifacts conditions. Correlation values close to 1 would indicate a strong relationship 
between signals. Ability to accurately display desired outputs will be vital for device use 
in long term patient monitoring. 
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2. Literature Review 
2.1 Heart Rate Variability 
HRV is often used as an indicator of the health of a patient‟s autonomic nervous system 
(ANS) [2]. The heart acts as a pump circulating the appropriate amount of blood 
throughout the body through rhythmic contraction and relaxations. HR contraction is 
triggered by the sino-atrial (SA) node, which consists of a group of specialized nerve 
cells that generate the necessary electrical impulse to initiate heart muscle contraction. 
Impulses are usually generated at a rate of 100-120 times per minute during rest [3].  
 
However, HR in healthy individuals typically ranges between 60-80 beats per minute 
(bpm) during rest and varies depending on body activity e.g. variations of the HR are 
most noticeable to an average person during times of increased physical stress. This is 
because HR is continuously controlled by the ANS whose net regulatory effect dictates 
HR. The ANS is the portion of the nervous system that controls involuntary functions in 
the body [3]. From its central nuclei located in the brain stem, activities are coordinated 
and controlled through afferent and efferent fibers of the peripheral nervous system. 
There are two branches of the ANS, the sympathetic (SNS) and parasympathetic nervous 
systems (PNS) that always work in an antagonistic manner to control organ function (see 
Figure 2.1). In the heart, stimulation by the SNS increases heart function such as HR, 
stroke volume etc. with a response time of about 5 seconds. In contrast, the PNS 
stimulation causes a decrease in HR, with an almost instantaneous response time. At rest, 
both SNS and PNS actively regulate HR with parasympathetic dominance. However, the 
balance between each system activity changes constantly based on a feedback mechanism 
to adapt instantaneous HR based on internal and external environmental conditions.  
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Figure 2.1: Comparison of the SNS and PNS on heart activity [3].  
 
Variability is controlled through the withdrawal or expressions of the two systems [4]. 
During rest, the ECG of healthy individuals exhibits rhythmic variation in R-R intervals, 
a phenomenon, known as respiratory sinus arrhythmia (RSA). RSA fluctuates at the 
phase of respiration; cardio-acceleration during inspiration, and cardio-deceleration 
during expiration. During exercises, HR increases as the parasympathetic system 
response is attenuated, creating a greater response due to the sympathetic nervous system 
[4]. The inability of the body to maintain self-regulation has associated itself in many 
common cardiac conditions. Most of these are caused by poor response of either the 
sympathetic or parasympathetic nervous systems, resulting in an abnormally high or low 
HR and an inability to adequately regulate the HR. This is subsequently represented as a 
poor HRV value, or a low standard deviation of the differences between normal-to-
normal beats. Problems relating to unbalanced SNS or PNS activity can be deduced from 
HRV analysis [5].  
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2.2 Medical Significance 
In addition to blood pressure, HR, and the ECG recordings, HRV is a significant 
diagnostic tool used to assess cardiovascular function during cardiopathophysiologies. 
Recent studies have observed a significant relationship between the autonomic nervous 
system and cardiovascular mortality, linking HRV with major cardiac ailments such as 
coronary artery disease (CAD) and SCD, or cardiac arrest (CA). The changes are usually 
manifested as abnormalities with the sympathetic and parasympathetic nervous system 
activities. As seen with CAD, activity within the PNS is attenuated while the response 
due to the SNS is accentuated, resulting in a perceivable increase in the HR and a 
reduction in HRV [6].  
2.2.1 Diagnostic Capabilities 
The major reason for the interest in measuring HRV stems from its possible ability to 
predict survival after heart attack. Several studies have related HRV changes to estimate 
the mortality rate of patients with specific cardiac problems. Significant indicators of 
potential problems have been associated with hypertension (HTN), congestive heart 
failure (CHF), CAD, and SCD [6]-[7]. Shown in Figure 2.2, are examples of the affects 
of CAD on HRV. Within the figure, it can be seen that all of the variability indices 
decrease with the presence of CAD. CHF patients have been shown to have a generalized 
decrease of all frequencies of variability. In addition, CHF patients also exhibited a 
decrease in the PNS functionality with a further decrease of the high frequency variability 
components such as respiration. SCD or CA in patients has been shown to have a direct 
relation to the power spectrum of HRV. Examples of this are through variations within 
the HRV indices and depressions of the HRV indices themselves [7]. CAD has been 
shown to be manifested as an attenuation of the PNS and an accentuation of the SNS [6]. 
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Figure 2.2: Affects of CAD presence on HRV [6] 
 
2.3 Current Methods and Practices 
Currently there are two major methods of analysis for HRV. While the formulas for HRV 
indices remain the same, the methods of signal acquisition differ. These two methods 
respectively are through ECG and PPG signals. Each of these two methods is used to 
acquire the normal beat-to-beat intervals of the heart rhythm.  
 
2.3.1 Electrocardiography 
The ECG is used to detect the electrical signature of the heart [8]. This is an important 
tool for determining the rate and rhythm of the heart. The ECG of the body is generated 
from the nerve impulses propagating within the heart. These are due to the depolarization 
and subsequent repolarization of the atria and ventricles of the heart muscles.  
 
A variety of methods are available for detection of the QRS complex of the normal heart 
beat. The most common method is through determination of the QRS peak by analysis of 
threshold values. By scrutinizing the signal amplitudes, it is possible to determine 
whether the signal has crossed over a specified threshold value. Analysis of the time 
between peaks can be used to determine the HR and HRV indices. A second method is 
through isolation of the QRS complex by way of limiting the signal frequencies to only 
the high frequency components of the QRS. Threshold detectors based on frequency 
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content can then be employed to detect the QRS complex, eliminating the remainder of 
the signal and noise while retaining a good trigger point for the cardiac cycle and 
subsequently for finding the instantaneous HR or time between beats.  
 
2.3.1.1 Principle 
The ECG is used to detect and monitor the electrical signals of the heart. This is done by 
determining the voltage potential across the heart, using two bi-polar leads placed on 
either side of the heart. When analyzing the ECG signal, there are multiple techniques for 
acquiring the signal from the body, these being dependent on the placement of the 
electrodes. Relative placement of the electrodes determines the area of the heart the ECG 
signal will be acquired from. As the electrical signals propagate through the heart, it is 
possible to view the ECG. Electrical propagations running perpendicular to the placement 
of the electrodes will not result in a visible potential change, while potential changes 
along the axis between the two electrodes will be recorded. An example of the possible 
placements for the electrodes is shown in Figure 2.3. The top row within the figure gives 
the general electrode placements for use with Einthoven‟s Triangle. These placements are 
Leads I, II, and III, respectively, where when the Lead I and III electrodes are placed 
perpendicular to one and other, the sum of the two resulting signals will provide the Lead 
II signal.  
 
Electrical signals obtained through the ECG indicate various portions of the hearts 
contraction cycle [10]. A sample of a single heart beat is shown in Figure 2.4, where the 
peaks of the various individual portions of the signal are noted. The initial small wave, 
labeled as the P wave, corresponds to the depolarization of the atria. The following QRS 
complex represents the depolarization of the ventricles as well as the repolarization of the 
atria. Finally, the T wave represents the end of the heart cycle with the repolarization of 
the ventricles. With the cycle concluded, the heart is then ready for the next beat.  
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Figure 2.3: Einthoven's triangle [9] 
 
 
Figure 2.4: Sample electrical signal for single heart beat indicating ECG electrical components 
 
The above signal of the ECG can be used to determine the heart function. As the QRS 
complex is representative of the beat of the heart, an analysis of the QRS complexes 
within a signal sample can allow for analysis of the heart function. Determining the 
number of QRS occurrences in a minute provides the number of beats per minute. 
Furthermore, an analysis of the time between QRS peaks will allow for a further analysis 
of the functions of the heart, with specific relation to the HRV.  
 
2.3.1.2 Methods for Acquisition 
For the majority of applications for ECG signals, the signals are acquired through gel-
based electrodes. These are used to reduce the effective resistance between the skin and 
electrode surface contact. However, problems can exist with this method. Since the gels 
used by these electrodes are water based, over time the gels can dry, causing an increase 
P 
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in the resistance between the skin and electrode contact surface. Other problems can exist 
from skin irritation caused by extended contact of the gel with the patient‟s skin [11].  
 
Dry ECG electrodes have been employed in an attempt to alleviate the problems 
associated with gel-based electrodes [11]. By employing a dry electrode, it is possible for 
the patient to wear the electrode continuously without experiencing any adverse effects. 
Furthermore, with the elimination electrode contact gel, resistance changes over time can 
be eliminated. For this to be an effective alternative to gel-based electrodes, the signal 
quality and reliability of the electrodes must be comparable. The final hypothesis was that 
dry ECG electrodes could be used as an effective alternative to gel-based electrodes in 
acquiring ECG signals and measuring accurate HRV values while preventing problems 
associated with long-term ECG gel use.  
 
2.3.1.3 Limitations of Electrocardiography 
Current methods for the determination of the ECG involve the detection of electrical 
potentials between two points using a reference ground. Potential problems with this are 
due to the necessity of requiring lead connections from the two points to determine the 
electrical potential across. Further problems that may be experienced with the ECG are 
that the ECG signals are not the sole electrical signals present within the body. All nerve 
impulses within the body can be represented as electrical signals of varying amplitudes 
and frequencies, see Figure 2.5. As such, signals with frequency ranges that overlap the 
frequency range of the ECG signal cannot be removed based on simple frequency range 
based filtration. Noted within the figure are the frequency cutoffs, shown as time period. 
From this, the ECG signal is seen as containing frequencies between 0.5 to 50 Hz. 
Overlapping the ECG are signals from the EMG and the electroencephalogram (EEG).  
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Figure 2.5: Frequency spectrum of bioelectric events [12]  
 
From Figure 2.5, it can be seen how it is possible for signal artifacts to enter into the ECG 
signal. Due to the location of the ECG electrode placements on the chest, there remains a 
significant chance for EMG signals to be recorded along with the ECG. Depending on the 
degree of muscle activity, there will be varying degrees corruption due to EMG noise. 
Should muscle activity be high enough, this may cause the ECG signal to not be easily 
distinguishable, and thus preventing analysis of the signal.  
 
2.3.2 Photoplethysmography 
2.3.2.1 Principle 
Photoplethysmography is based on the differences in light absorbance due to changes in 
arterial configuration during the various stages of the cardiac cycle. During the cardiac 
cycle, the heart undergoes rhythmic contractions (systole) and relaxations (diastole) 
creating pressure changes in blood vessels. No blood is pumped out when the heart is 
relaxing and refilling. To ensure continuous blood flow in the capillaries, arteries are 
functionally specialized to serve as pressure reservoirs [16]. Elastin fibers present in 
arterial walls enable them to stretch and accommodate the extra blood volume during 
systole. Arteries therefore behave as balloons, changing their diameters during the 
different phases of the cardiac cycle (see Figure 2.6).  
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Figure 2.6: Arteries acting as pressure reservoirs by varying cross-sectional area [16] 
 
During systole, there is more blood volume in the arteries resulting in an increase in 
arterial diameter. The optical path length of light increases, hence more light is absorbed 
by blood. This causes a decrease in the amount of transmitted light, and so the PPG 
waveform reaches a minimum peak. The opposite is true during diastole and the PPG  
waveform reaches a maximum peak (see Figure 2.7). The PPG waveform thus consists of 
a distinguishable AC component due to pulsatile arterial blood flow. The DC component 
represents the composite absorbances of the non pulsatile portion of arterial blood, as 
well as of other tissue types such as veins, bone, muscles, etc.  
 
 
Figure 2.7: Light absorption through tissue as a function of pulsatile blood flow [17]                                                                                                                                     
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Changes in arterial blood volume during heart activity are thus reflected as pulsations in 
arterial blood flow. Signal processing algorithms can thus be applied to compute pulse 
rate (PR), and pulse rate variability (PRV), and thus HR and HRV. 
 
2.3.2.2 Sensor Probes 
The PPG sensor probe consists of a light emitting source and a photodetector. The 
amount of light that is transmitted from the light source is detected by the photodetector 
as a current. This current, proportional to the amount of transmitted light, is converted to 
a voltage by a trans-impedance amplifier. The detected signal undergoes further 
conditioning such as filtering and signal amplification to extract the PPG waveform. 
 
2.3.2.3 Methods for Light Detection 
PPG sensors can be classified into two types based on the relative position of the LED 
with respect to the photodetector, namely transmittance and reflectance mode sensors 
[14]. 
 
Transmittance mode 
Signal detection via transmittance mode is dependent on light being transmitted through 
tissue.  It thus requires soft tissue and minimal bone tissue (that significantly reflects 
light) to allow maximal transmittance of light. The LED and photodetector are placed on 
opposite sides of tissue thus requiring a small tissue length (see Figure 2.8a). As a result 
transmittance sensors are limited to peripheral locations of the body such as the earlobe, 
fingers, nasal septum, toes etc.  
 
Reflectance mode 
Reflectance photoplethysmography is dependent on light being reflected from tissue and 
light reflection is usually facilitated by the presence of bone tissue. LED‟s and 
photodetectors are placed adjacent to each other in the sensor (see Figure 2.8b). As a 
result of this architecture, reflectance sensors can be placed at various locations in the 
body.  
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Figure 2.8: Transmittance (a) and reflectance (b) PPG probes [14] 
 
Transmittance versus Reflectance 
The main advantage of transmittance sensors is that most light is transmitted through soft 
tissue. Finger sensors are the most popular commercial probes used in clinical settings for 
patient monitoring. However as transmittance probes are limited to peripheral locations, 
sensors are easily susceptible to inaccuracies due to environmental conditions such as 
vasoconstriction. Reflectance photoplethysmography is often facilitated by the presence 
of bone tissue, with higher amplitude being obtained from regions such as the forehead 
and chest [18]. Reflectance probes can be used both invasively and non-invasively in 
many areas in the body, especially those that cannot be accessible by transmittance 
probes. Wouda et al utilized a tampon-like vaginal reflectance PPG sensor to demonstrate 
differences in vaginal vasocongestion in women with and without dyspareunia during 
sexual arousal [19]. Sometimes, reflectance probes are most applicable when monitoring 
HR during conditions of compromised peripheral blood flow [20].  
 
Motion artifacts adversely affect the accuracy of PPG measurements. Peripheral sensors 
such as the finger and toe are easily susceptible to artifact due to movement of limbs, 
limiting patient activity during recordings. Johnston et al demonstrated reduced motion 
artifacts in reflectance sensors, obtaining greatest signal stability from forehead sensors 
during motion [21]. However, motion artifacts reduction is still one of the many 
challenges in designing long term wearable health monitors where high specificity is 
desired [22].  Several approaches like motion artifacts removal or correlation such as in 
simple analog filtering and software adaptive filtering have been developed to attenuate 
the problems due to this limitation. 
 
(a) (b) 
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Power consumption is also an important criterion in LED selection. To guarantee a good 
PPG signal, the intensity of light transmitted or reflected must be strong enough to be 
detected by the photodetector. The intensity of incident light is directly proportional to 
the LED drive current. LED‟s are usually 2-10% efficient, thus most of its energy is 
dissipated as heat [14]. While power consumption may not be a problem with AC 
powered PR monitors, it is the main limitation when designing battery operated and 
portable units as most of the power is consumed by the LED e.g. in a microcontroller 
PPG unit, 70% of the power is consumed by LED‟s and RF transmitter [18]. Savage et al 
demonstrated the preference of a reflectance sensor with a large photodetection area as 
the estimated battery life was 18 times higher than transmission mode sensor, due to the 
lesser current requirements for reflectance sensors (1.9-3 mA) compared to transmittance 
sensors (19.6- 46mA) [23].  
 
2.4 Electrocardiography versus Photoplethysmography 
HRV is a measure of changes in instantaneous HR. It is easily calculated by analyzing 
time series of beat-to-beat intervals from ECG tracings from its distinguishable QRS 
complex. Although the P wave serves as a reference point for onset of cardiac events, the 
R wave is generally preferred in HR measurements due to higher signal to noise ratio 
(SNR) [24]. However, the ECG signal is susceptible to baseline drift, power line noise, 
motion artifacts due to electrode movement as well as electrical muscle activity 
interference [25]. ECG signals are also traditionally acquired via gel electrodes, to 
maintain good surface contact. However, gel electrodes are usually uncomfortable for 
patients especially in long term recordings because of potential skin irritation, as well as 
drying [11].  
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Figure 2.9: Illustration of beat-to-beat intervals within ECG and PPG signals [3] 
 
Alternatively, HRV data can be extracted from the PPG as the heart cycle is reflected via 
pulsations in arterial blood flow (see Figure 2.9). Comparative studies have shown 
correlation between HRV measurements obtained from ECG and PPG signals [26]. 
Mendelson et al compared HR and HRV data obtained from simultaneous ECG and 
reflectance mode PPG recordings [27]. Correlations coefficients of 0.9 and 0.91 were 
observed for HR/ PR and HRV/PRV values, respectively. Bolanos et al. also observed 
similar correlation using a PDA-based system, with sophisticated HRV analysis such as 
autoregressive modeling, Poincaré plots, standard deviation etc. to better demonstrate 
correlation between the two signals [25]. 
  
PPG sensor systems are more compact and convenient for patient use. The PPG signal is 
detected optically, making it less susceptible to electric interference. The PPG signal 
requires only one wire for signal acquisition as opposed to three for the ECG. This 
reduction in wire content is thus desirable, especially during ambulatory conditions [25]. 
PPG signals also offer the versatile advantage of obtaining other vital physiologic signals 
like breathing rate and area perfusion, hence offering a better range of clinical 
applicability. PPG monitors can also be incorporated in non medical instruments, 
increasing their versatility. Kim et al. developed an armband sports MP3 player 
incorporating a HR monitoring unit via reflectance photoplethysmography [28]. 
Comparison with a professional medical sensor demonstrated an effectiveness of 
calculating PR within an error of <3% from 20 subjects. 
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2.5 Mathematical Models 
In 1996, a Task Force of the European Society of Cardiology and North American 
Society of Pacing and Electrophysiology set standards for calculating HRV, to harmonize 
HRV measures. These measures involve time domain and frequency domain analysis [7]. 
Both methods utilize the same data set, using mathematical interpolations such as Fourier 
transforms to move between domains. The flow chart in Figure 2.10 outlines the 
necessary steps taken to process signals for HRV analysis. HRV can thus be expressed 
under different parameters and models, and the choice of methods depends primarily on 
the application and length of data recording. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.10: Flow chart summarizing steps for ECG HRV analysis [7] 
 
2.5.1 Signal Conditioning 
A sequence of beat-to-beat intervals can be obtained from ECG signals using appropriate 
software/hardware algorithms. Atapattu et al developed a simple computer algorithm for 
HRV acquisition and analysis [24]. They described a sequence of discrete normal to 
normal (NN) intervals as a grossly approximated impulse train of unit impulses that 
temporally locate peak occurrences. This can mathematically be described as an infinite 
series set of spaced impulses, δ (see Equation 1). 
RR interval 
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RR data 
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Artefact 
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The time interval between consecutive impulses located at times s(t) and s(t+1), for t=0, 
1, 2,…, n can be described as a series x(t), representing the normal to normal (NN) time 
interval series (see Equation 2). 
 
 )1()()(  tststx  (2) 
 
The analysis of HRV assumes NN intervals are obtained from normal heart beats [29]. 
Figure 2.11 shows an irregular heart beat due to premature ventricular contraction. This 
leads to the absence of the P wave as a result of the lack of atrial contraction.  
 
Figure 2.11: Irregular heart rhythm shown as PVC [3] 
 
The PPG waveform is diminished due to decrease in heart stroke volume. The consequent 
R-R interval is thus significantly larger than adjacent intervals. Such increased R-R 
intervals are typically rejected from the HRV processing algorithm. This is because their 
irregularity can introduce erroneous deviations in HRV and cause misinterpretation of 
results. For this reason data after R-R editing is termed normal to normal or NN intervals 
(see Figure 2.10). 
2.5.2 Time Domain Analysis 
Time domain methods for HRV analysis are derived by evaluating the HR or the intervals 
between successive beat-to-beat or normal-to-normal (NN) intervals. Simple time domain
 
variables include the mean NN interval,
 
the mean HR, the difference between night and 
day HR etc. Variations in NN intervals can also be observed to evaluate changes in 
instantaneous HR secondary to respiration, tilt, drug intake, exercise etc. 
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2.5.2.1 Statistical Methods 
Several statistical indices have been developed to quantify HRV, and these indices are 
usually chosen based on length of time of ECG recordings. A typical manipulation 
involves calculating the mean and standard deviation of HR. The simplest and most 
commonly used index is the standard deviation of the NN (SDNN) interval (unit=ms) 
[29]. 
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 Where: NNi = duration of the i-th NN interval in the analyzed ECG (ms) 
 n = number of all NN intervals  
 m = mean duration 
 
However, for large values of n, with the assumption that the mean of differences between 
neighboring intervals is negligible, the formula can be approximated into another HRV 
index, the root mean square of successive differences, rMSSD (unit: ms). 
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The SDNN and rMSSD indices are preferentially used for short term, steady state 
analysis because vital information can be omitted in longer recordings as signals are 
averaged out. This problem can be resolved by adapting the formula for shorter time 
segments to take into account variations in longer recordings. Other indices to quantify 
HRV are listed in Table 2.1 below. 
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Table 2.1: Statistical HRV Measures 
Measure Unit Description 
SDNN 
index 
ms 
Mean of the standard deviations of all NN intervals for all 5 minute 
segments in the entire recording 
SDANN ms 
Standard deviation of the averages of the NN interval in all 5 minute 
segments of the entire recording 
NN50 ms 
The number of interval differences of successive NN intervals 
greater than 50 ms 
pNN50 ms 
The proportion derived by dividing NN50 by the total number of 
NN interval 
 
There exist no standard prognostic values for rMSSD and SDNN indices, although some 
studies have tried to establish some ranges. This is because identical statistical measures 
can result due to entirely different causalities. Patients are generally monitored over time, 
and from various studies with cardiac patients, the general pattern observed was the 
inference of better survival from increased HRV indices. In a study by Bilchick et al., 179 
patients with CHF were treated either with doses of amiodarone (medication used for 
irregular heart beat) or a placebo and monitored over about a 4 year period [30]. Among 
127 patients, an SDNN<65.3ms (p=0.0001) was a predictive value in worse survival, 
with an increase of 10ms of SDNN resulting in 20% decreased mortality risk. A study by 
UK-Heart of 433  CHF patients monitored over 482±161 days, indicated annual mortality 
rates for SDNN at 5.5% for >100 ms, 12.7% for 50 to 100
 
ms, and 51.4% for <50 ms 
[31].  
 
One limitation of statistical methods is that their accuracy depends on the quality of the 
R-R data obtained. This is sometimes difficult in long term recordings (e.g. 24 hrs), as it 
requires careful maintenance of recording equipment, lead stability as well as patient 
cooperation [29]. The possibility of introducing artifact errors is likely if abnormal R-R 
intervals are not rejected. To ameliorate this problem, Kleiger et al proposed that the 
durations of neighboring R-R intervals of sinus rhythm usually do not differ by more than 
20%, and thus only the set which satisfies this requirement be included in the respective 
calculations [32]. However, this approach may not always be successful in properly 
rejecting abnormal intervals. For long term recordings, statistical measures should be 
used when the quality of NN interval data is guaranteed.  For 5 minute periods it is 
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believed that these measures quantify the slow components of heart although there is a 
lack of physiological understanding for this phenomenon [29].  
2.5.2.2 Geometrical Methods 
Geometrical methods provide visual representations of HRV data by converting the series 
of NN intervals into a geometric pattern. This is usually done using three approaches (a) 
converting a geometric pattern into an HRV measure, (b) obtaining parameters by 
interpolating the geometric pattern to a mathematically defined shape and (c) classifying 
geometric shapes into several pattern-based categories representing different HRV 
classes [7].  
Interval Tachogram 
A simple graphic representation is plotting NN interval duration against time, an interval 
tachogram. However, given the long and repetitive nature of the heart cycle, the 
tachogram is often cumbersome to analyze and thus preferentially mapped to the 
frequency domain for analysis. It is usually suitable when analyzing HR trends during 
specific activities. Figure 2.12 shows an interval tachogram recorded from a patient using 
Mini Logger® monitor, with a strapped chest electrode. As observed, interbeat interval 
decreases with increases in body stress (e.g. walking, jogging) due to increased HR [33].  
 
 
Figure 2.12: Interval tachogram from Mini Logger® monitor during various activities; redrawn 
from [33] 
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HRV Triangular Index 
Another method involves calculating HRV triangular index from a sample density 
histogram of NN intervals. This method is most suited in histograms that have a 
dominant peak, where the histogram assumes a triangular shape whose height 
corresponds to the number of R-R intervals with modal duration (H), and area of the 
histogram corresponds to number of all NN intervals used to construct the histogram, A 
[34]. The baseline width i.e. HRV index is then computed by the fraction A/H. Based on 
the spread of the histogram, individuals with defective heart rate variability can easily be 
discerned, as can be seen in Figure 2.13. A decrease in histogram spread indicates a low 
HRV triangular index. Also observe the reduction in modal R-R intervals, compared to 
that of a normal person. 
 
 
Figure 2.13:  N-N interval histogram to compute HRV triangular index [34] 
 
In a study of 385 survivors of acute myocardial infarction, Odemuyiwa et al 
demonstrated that HRV triangular index of < 20U had a sensitivity of 75% and specificity 
of 76% in the prediction of arrhythmic events, 40% and 83% respectively in the 
prediction of sudden deaths, respectively [35]. 
 
Poincaré Plots 
HRV data can also be analyzed using a Poincaré plot, where each NN interval is plotted 
as a function of the previous interval (see Figure 2.14). The data can be interpreted 
visually or quantitatively, and one advantage is that abnormal beats are usually observed 
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as outliers on the plot. The Poincaré plot typically appears as an elongated cloud of points 
oriented along a line-of-identity. The dispersion of points perpendicular to the line-of-
identity reflects the level of short-term variability (ΔR-Rt), while the dispersion of points 
along the line-of-identity is thought to indicate the level of long-term variability (ΔR-Rr) 
[36].  
 
 
Figure 2.14: HRV analysis using Poincaré Plot [37] 
 
 
Some studies have classified Poincaré plots based on their relative patterns such as 
torpedo or comet shape, which indicate various ranges of HRV (see Figure 2.15, A and 
B).  
 
Contreras et al. observed that lagged Poincaré widths and spectral indices might be a 
useful tool to distinguish normal from pathological HRV, recommending additional tests 
for validations [39]. Paškevičiūtė et al demonstrated Poincaré plots constructed from long-
term ECG recordings of R-R intervals might be potential tool in diagnostics of atrial 
fibrillation, atrial flutter and other supraventricular dysrhythmias (see Figure 2.15 C) [38]. 
This was as a result of observed characteristic plot shapes in patients after long term ECG 
recordings of 43 patients suffering with respective conditions.  
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Figure 2.15: Examples of Poincaré plot patterns with different HRV values [38] 
 
The weakness of using Poincaré plot analysis lies in the subjective interpretation and 
classification of plot patterns, hence no precise definition for the conditions for which 
they represent. The studies above assessed their results by comparing Poincaré between 
normal and cardiac patients, and assessing the change in the plot geometry in patients 
monitored over time. Nonetheless, geometric methods can often provide a reasonable 
assessment of HRV when the quality of R-R interval does not permit the use of statistical 
methods. Another important factor to note is that these methods can only be valid from 
data generated from a substantial number of data points and the longer the recordings 
being more effective [29].  
C 
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2.5.3 Frequency Domain Analysis 
With additional resampling and Fourier transforms, the interval tachogram can be 
analyzed to obtain its frequency components. The HRV spectrum, usually obtained from 
short term recordings of 2 to 5 minutes, contains three main characteristic components. 
These frequency components give an insight on the influence of central nervous activity 
on the respiratory cycle (see Figure 2.16).  
 
 
Figure 2.16: Frequency power spectrum of HRV [40] 
 
Table 2.2: Frequency Domain HRV measures 
Measure Unit Description 
High Frequency 
(HF) 
ms
2
 Total power from 0.15 to 0.4 Hz 
Low Frequency 
(LF) 
ms
2
 Total power from 0.04 to 0.15Hz 
Very Low 
Frequency (VLF) 
ms
2
 Total power from < .04Hz 
LF/HF ratio none Ratio of high frequency to low frequency component 
Total power ms
2
 
The variance of NN intervals over the temporal segment  
usually ≤ 0.4 Hz 
 
The HF component reflects parasympathetic tone and fluctuations caused by respiratory 
sinus arrhythmia. The LF component reflects of both parasympathetic and sympathetic 
tone. Frequencies in the very low ranges (VLF) are typically not good diagnostic 
indicators and do not have a well defined physiological explanation. The LF/HF gives the 
balance between parasympathetic and sympathetic activity on HR. Spectral recordings 
over longer recordings of a 24-hour period usually include an Ultra Low frequency 
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(ULF) component, from ≤ 0.003Hz [7]. Depending on the level of body metabolism, the 
distribution of frequency contents changes depending on to HR [4]. Bigger Jr. et al 
studied 715 patients, 2 weeks after myocardial infarction to establish the relationship 
between frequency domain measures of HRV and mortality during 4 years of follow-up 
[43]. They demonstrated strong association between total ULF and VLF power 
components in predicting arrhythmic deaths. 
2.6 Current Devices 
Several ECG HRV measuring systems that utilize different algorithms processing 
methods have been developed. The Mini Logger Series 2000 is a commercial portable 
system that measures interbeat HR (IBI) intervals by a polar chest belt electrode system 
[33]. A pulse is transmitted each time an ECG “R” wave is detected to a hardware sensor 
suite. This unit can be programmed via software to record data at user selected intervals. 
The software also allows for setting parameters for data collection, downloading and 
charting results. Figure 2.12 shows a sample tachogram obtained from the device. US 
Patent 20060287605 developed by Lin et al describes a versatile portable HRV monitor 
with a built in central processing unit to perform time and frequency HRV analysis [44]. 
ECG signals are obtained via two electrodes. The systems algorithms allow for the 
elimination of irregular R-R intervals. HRV measures obtained from the device include 
time domain analysis measures such as mean NN interval; mean HR, standard deviation, 
rMSSD indices as well as frequency domain analysis of HF, LF, HF/LF components. The 
device also includes a data storage unit and data module that can transmit data via a USB 
interface. Data can also be wirelessly transmitted via Bluetooth to a personal computer, 
cell phone, database etc.  
 
The existence of modern wireless technology has enabled the flexibility of patient 
monitoring options via wireless wearable sensors, for hospital environment, home use as 
well as outdoors. The convenience, portability and versatility of the Personal Digital 
Assistant (PDA) devices in health care management, has made them a popular choice for 
monitoring devices. Wearable sensors usually possess a Bluetooth radio to transmit 
acquired signals to a PDA unit. This data can be analyzed within the PDA using software, 
or uploaded to a web-server. This versatile platform allows for the easy transmission of 
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patient data, facilitating and accelerating patient care. PDA based systems developed by 
Mendelson et al and Bolanos et al compared and correlated HRV data obtained from PPG 
and PPG systems. Karlsson et al developed a similar PDA based system for house 
nursing; however their device assessed HRV via real time analysis of Poincaré plots [45]. 
They selected Poincaré plots as the preferred method of visualization because the overall 
geometrical pattern is less sensitive to error, as measurement errors such as detection 
errors and artifact can often be discerned as outliers. They stipulated that patients with 
atrial fibrillation would benefit from this device, due to the irregular and chaotic nature of 
their plots, providing and easy way even for patients to discern recurrence of atrial 
fibrillation. Further developments for their device included developing a smaller data 
acquisition module with improved battery life. 
 
2.7 Future Developments 
Future developments in the field are mainly focused on attaining a better signal while 
reducing general signal noise due to motion artifacts. Each of the methods of signal 
acquisition is being further adapted for incorporation into real-time monitoring systems. 
Such systems will allow for the user to gain more mobility, which can be especially 
beneficial for reducing overall healthcare costs [41]. Further benefits of increased 
mobility are allowing for long-term signal acquisition and analysis. This is especially 
important for the detection of rare signal anomalies or arrhythmias.  
 
The ECG electrode design, with the development of dry ECG electrodes, is being applied 
to applications requiring continuous monitoring [41]. Problems associated with HRV can 
indicate increased risks of SCD [7]. Due to this it may be sometimes necessary to delay 
patient discharges. Developments of comfortable electrode systems designed for long-
term monitoring will allow patients to be safely discharged with mobile monitoring 
systems [41]. Further advances include the development of wireless ECG monitoring 
systems. Such a device may allow for the patient to have further increased mobility while 
also allowing for transmission of ECG telemetry [42]. Other developments with the ECG 
signal are with the further understanding of the specific segments of the ECG signal. 
Specifically this applies to the P-P and P-R intervals [7]. Each of these features within the 
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signal can provide important information regarding the cardiac health of a patient. Future 
developments along these lines will provide for better detection of the P waves within the 
ECG signal. These methods for the ECG are being used to help facilitate long term 
monitoring of patients outside of the hospital environment.  
 
PPG sensor developments are focused on the development of wireless transmission 
technology. This will help to eliminate potential problems with motion artifacts in 
addition to allowing for a more flexible sensor platform [23]. These developments will 
allow for the subject to have an increased range of mobility, allowing for earlier patient 
discharges while utilizing patient telemetry transmission for remote monitoring.  
 
Further developments for HRV monitoring include improvements in the mathematical 
models used, and correlations between the HRV indices and other physiological functions 
[7]. Current methods for HRV analysis do not provide a wide spectrum of analysis 
methods, especially under changing environmental conditions. Signal correlations can be 
used to determine the affects of HRV on various physiological signals. This is especially 
important in determining how HRV is manifested throughout the body and in 
determining alternative methods for determining the HRV indices. An example of this 
can be shown within this report in the correlation of ECG and PPG signals.  
 28 
3. Project Approach 
3.1 Hypothesis 
HRV has been shown to have certain predictive values for patients who are likely to 
suffer from SCD. To date, cumbersome methods have prevented the use of HRV as an 
effective tool. Although the human ECG is easy to acquire, utilizing gel-based electrodes 
makes it impractical for use in a dynamic setting where subjects remain active. 
Alternatively, HR information can also be obtained non-invasively from the PPG signal. 
However, correlation between HRV derived from the ECG or a PPG signal need to be 
established. This project is based on two hypotheses.  
 
3.1.1 Dry Electrodes 
Gel-based electrodes can cause skin irritation during extended use and signal quality may 
degrade over time due to electrode drying. Use of dry electrodes can alleviate the 
problems associated with gel-based electrodes while still maintaining an adequately good 
signal quality for analysis. This will allow for more effective long term patient 
monitoring.  
 
3.1.2 PPG Signal Alternative 
Heart electrical activity is reflected in pulsatile arterial blood flow, so PPG signals can be 
used as a reliable non-invasive alternative to obtain HRV data. This avoids the problems 
that arise with difficulties in acquiring ECG such as baseline drift, EMG interference and 
utilizing gel based electrodes in active subjects. 
 
3.2 Specific Aims 
The overall goal of the project is to acquire ECG and PPG signals simultaneously, and 
calculate HR and PR, as well as respective variability indices (SDNN and rMSSD 
indices). Waveforms and computed indices should be displayed. The design should also 
have set of controls for user to change certain parameters.  
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3.2.1 Photoplethysmography Acquisition 
The two major aims addressed in designing the PPG unit of the device include optimizing 
power consumption as well minimizing motion artifacts to prevent PPG system 
inaccuracies. Optimizing power consumption assumes most of the power in the device 
circuit will be used to drive the LED in the PPG circuit. It was assumed that the dominant 
power consumption was due to the LED. Other factors that may also affect the power 
requirement include LED emission wavelength and PPG sensor mode. The effects of 
varying LED drive current amplitude as well as current duty cycle will be investigated. It 
is also assumed that motion artifacts introduced in the device are due primarily to the 
location of the PPG sensor, as well as the relative motion of the sensor at the attachment 
site. Sensor locations will be evaluated to determine which is least susceptible to motion 
artifacts. 
 
3.2.2 Electrocardiogram Acquisition 
The specific aim of the electrocardiogram portion of the system is to acquire the ECG 
signal through experimental dry electrodes. This should be done with a minimum of 
hardware components to decrease the possibilities of component failure and reduce 
overall device cost. Signals for the ECG system are to be examined based on the QRS 
complex locations. From this information, the time between peaks of the signal is to be 
determined. This will then be used to calculate the HR of the subject and from this to 
determine the HRV indices.  
 
3.2.2.1 Comparison of Dry Electrodes with Gel Electrodes 
The dry electrodes used for the system must be comparable in their functioning to gel-
based electrodes. The immediate goal of the dry electrodes is to produce a signal with 
similar quality to gel-based electrodes. Furthermore, the dry electrodes must limit 
potential motion artifacts and additional noise contained within the system. During long-
term use, the electrode system selected must prevent signal degradation due to electrode 
gel drying. Finally the electrodes chosen must provide for decreases in the potential for 
skin irritations caused by materials used in the electrode construction.  
 
 30 
3.2.3 Correlation of ECG and PPG signals 
The final aim is to correlate HRV and PRV obtained from simultaneous ECG and PPG 
recordings, i.e. respective rate and variability indices. Algorithms should minimize 
standard error of estimate between PPG and ECG derived indices. A correlation 
coefficient close to 1 will also indicate a strong relationship between the two signals, 
demonstrating that the PPG can be used as an alternative for HRV calculations.  
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4. Analysis of Needs and Specifications 
The main objective of this MQP project is to design HRV monitor. Current methods 
utilize the ECG signal for HRV analysis, via time domain and frequency domain 
analysis. Alternatively, the PPG can be used for HRV data analysis since PPG waveforms 
are caused by pulsatile arterial blood flow during the various stages of the heart cycle.    
 
4.1 Initial Client Statement 
For this project, Professor Yitzhak Mendelson and Suresh Atapattu were considered the 
sole clients. They provided the MQP group with the following initial client statement, 
and a budget constraint of $450.  
 
The correlation between HRV derived from the ECG or a PPG signal needs to be 
established. Since SCD occurs during normal daily function, it is imperative to have a 
reliable monitoring system that can function in normal life situations. The goal of this 
project is to design and construct a small microprocessor-based ECG/PPG recording 
device that will acquire the ECG and PPG signals of a moving person simultaneously 
using surface contact non-gel electrodes and optical PPG sensor.  
 
Given the brief nature of the initial client statement, the MQP group clarified clients‟ 
objectives through gathering more information through literature search, client interviews 
and brainstorming sessions, in order to develop a more detailed engineering statement 
expressing the clients‟ wants. The clients wanted a clinically acceptable device for HRV 
monitoring with the versatility of offering a wide variety of desirable outputs. Desired 
system outputs included signal waveform as well as HR/PR rate and respective variability 
indices. The clients also requested that rMSSD and SDNN variability indices be 
displayed in real time. 
 
4.2 User Requirements 
The MQP group identified two types of users for the device: patients and physicians. The 
device was going to be used for continuous HR monitoring by a patient at risk of SCD. 
To enable patient carry out some normal daily activities, design considerations for the 
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patient included ease of use, as well as patient comfort and convenience. The physician 
has to be able to make predictions and administer proper therapeutic or preventive action 
based on interpretation of patient data. This is especially critical given the importance 
that HRV data can sometimes predict mortality after a patient survives a cardiac episode. 
Therefore, the MQP group determined that the device outputs were to be accurately 
calculated and displayed in a clear manner. The outputs of interest to the physician 
include ECG and PPG signals, HR and PR, as well as computed HRV and PRV indices. 
The accompanying software also was going to be easy to use, with minimal technical 
knowledge. The MQP group determined that the device should allow for function 
controls, offering the flexibility of changing desired system outputs or modifying system 
parameters. The device was also to possess high and low alarm controls to monitor 
patient HR within a certain range as desired by the physician. The MQP group also 
determined that signal storage was important to allow retrieval of patient data to create 
patient records for better health care management. Desirable features in clinical 
monitoring devices, such as a QRS detection beep would also help to indicate each heart 
beat.  
4.3 Objectives  
Based on client interviews and user requirements, the MQP group developed a set of 
design objectives and sub-objectives and ranked them in a pairwise comparison chart 
(PCC) summarized in Table 4.1, to determine what area to focus most on during the 
design. Each element in a row was compared to a corresponding column element. Row 
elements were assigned a score of 1 if considered more important than column feature, 0 
if considered less important and 0.5 if equally valued. An (x) is assigned for the same row 
and column entry (Note: this PCC model will be applicable throughout the whole design). 
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Table 4.1: Pairwise Comparison Chart for Design Objectives 
 
User  
Friendly 
Reliable Versatile Safe Total Weight % 
User  Friendly x 0 0 1 1(+1)=2 20% 
Reliable 1 x 1 1 3(+1)=4 40% 
Versatile 0 0 x 1 1(+1)=3 30% 
Safe 0 0 0 x 0(+1)=1 10% 
Total 100% 
 
1. The device should be reliable (40%) 
a. The device outputs should be accurate 
b. The device should correlate data obtained from PPG and ECG  
c. The device should have minimal parts to minimize device failure 
d. The device should be durable to withstand extended patient use  
2. The device should be versatile (30%) 
a. The device should provide visual and numeric outputs  
b. The device should have dual ECG and PPG channels 
c. The device should store data for further signal analysis 
d. The device should be battery operated 
i. The device battery should require minimal change 
3. The device should be user friendly (20%) 
a. The device should display outputs in a clear manner  
b. The device should allow for physician control of output parameters 
c. The device should have easy user instructions and software interface 
d. The device sensors should be comfortable to wear 
e. The device hardware should be portable 
i. Cell phone to PDA size range 
4. The device should be safe (10%) 
a. The device hardware should have no sharp edges 
b. The device should be electrically insulated 
 
The MQP group ranked system reliability highest due to the critical nature of the device. 
Inability of the device to accurately calculate and display its values may have severe 
consequences if proper therapeutic action is not administered. It was also necessary to 
design a device that would be able to correlate data obtained from ECG and PPG systems 
in order to demonstrate that PPG signals can be used alternatively to calculate HRV. The 
MQP group determined that minimal design parts are desired to decrease the probability 
of device failure. It was also important to assure that device withstand extended patient 
use for long-term monitoring.  
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The MQP group ranked device versatility second to provide a wide range of options that 
the physician could use to facilitate diagnosis. These included ECG and PPG signal 
displays as well as HR, PR, HRV and PRV indices. The MQP also decided to design a 
dual channel, as opposed to two separate devices to facilitate simultaneous recording of 
ECG and PPG signals and make better signal comparison.  Since both signals are 
processed differently due to their different characteristics, their systems can be made 
independent. Data storage was also necessary for further signal analysis and creation of a 
patient database. The MQP group decided that a battery operated device would also allow 
for easy patient transportation as well as operate during lack of electrical power.  
 
The MQP group evaluated that user friendliness was a design consideration applicable to 
both patients and physicians. It is vital that system outputs be displayed in a clear manner 
in order to facilitate easy comprehension of displayed results. The MQP group 
determined that data interpretation is usually facilitated by its layout as well as aesthetics. 
It was also necessary to allow the physician a degree of control over certain parameters 
e.g. alarm controls, type of data displayed etc. so that the device could serve as a better 
tool for analysis. Device instructions had to be easy to interpret, anticipating potential 
problems that could arise during use. The device sensors had to be comfortable for long 
term patient use. The MQP group determined that the ideal device size was to be within a 
cell phone to PDA size range to facilitate device transportation. Overall, the duality of 
device user i.e. patient and physician was going to pose conflicting design considerations 
in achieving a balance between patient comfort and ease of use as well as clinical 
acceptability.  
 
Although device safety is important, the MQP determined that that there was low risk of 
electrical shock due to the battery operated hardware and so this would not contribute a 
significant amount of difficulty in ensuring electrical safety. For an average adult, the 
amount of current necessary to trigger ventricular fibrillation is between 75 and 400mA 
[12]. The design of the device will have currents no more than 15mA to minimize risk of 
macro shock. An insulated device case with no sharp edges was to be used for the device 
hardware with RoHS compliant materials.  
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Figure 4.1: Weighted objectives tree 
 
4.4 Constraints 
The MQP group identified the following design constraints that could limit the 
implementation of the design project: 
 Budget: Funding for the device implementation was limited to $450 from the WPI 
Biomedical Engineering Department 
 Regulatory Requirements: The MQP group had to design a device in compliance 
with FDA regulations and ASTM standards to validate its use as a clinical device. 
 
4.5 Revised Client Statement 
Based on the weighted objectives, the MQP group developed a revised client statement 
which was approved by the client. This was done in an effort to better define the final 
goals of the project. Due to limited knowledge of the MQP group, the microprocessor 
unit of the device was replaced by combinational hardware and software routines. 
Software processing for the signal was via LabVIEW software. The intended outcome 
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would be to develop algorithms that would be later used in a microprocessor based 
device. The following is the revised client statement: 
 
The goal of this project is to design and build a functional PC-based HRV monitor. The 
device will be a versatile dual-channel monitor capable of calculating HRV and PRV 
indices from electrocardiograph (ECG) and photoplethysmograph (PPG) signals, 
respectively. ECG signals will be collected via dry electrodes and PPG signals from a 
standard sensor interface. The device will include a hardware portion encasing the bio-
amplifiers and filters for acquiring the ECG and PPG signals. Signals obtained will be 
filtered and processed by hardware and software using LabVIEW Software. Signals will 
be refreshed and updated at least every five seconds. Outputs of the system will include 
displays of the ECG and PPG signals as well as respective rate and variability indices. 
Raw waveforms will be stored for later access and analysis. The hardware will operate 
on battery power, continuously for more than twenty-four hours. The total budget of the 
design should not exceed $450.  
 
4.6 Functions 
The MQP group selected the black-box method (see Figure 4.2) as the most appropriate 
tool to determine device functions that would realize stated objectives by identifying 
system inputs and outputs. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2: Design black box with inputs and outputs 
 
This enabled the device sub-functions to be identified in a sequential flow of events by 
discerning how the system would process the signal to obtain the desired output. The 
MQP group developed a transparent box, shown in Figure 4.4, using considerations for 
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processing physiological signals (Figure 4.3) as well as the as HRV data (see Figure 
2.10).  
 
 
Figure 4.3: Physiological signal processing using sensors, signal processing, and outputs [56] 
 
4.6.1 System Inputs 
The MQP group had to design appropriate transducers that will be used to transform the 
signals of interest into electrical signals. These included electrodes for the ECG and a 
standard photodetection unit for the PPG signal. These transducers had to be 
appropriately packaged to guarantee good surface contact, and signal quality as well as be 
comfortable for the user to wear. Battery power was going to be used to power the device 
hardware. The MQP group identified EMG noise, optical interference and motion 
artifacts as primary sources of noise, and brainstormed several options to minimize their 
effect on system output accuracy.  
 
4.6.2 Signal Amplification and Filtering 
Physiological signals typically have low amplitudes and have to be amplified within the 
order of about 200-1000. These are effectuated by bio-instrumentation amplifiers for the 
ECG and a transimpedance amplifier for the PPG signal.  There is also the presence of 
other physiological signals and high frequency noise which have to be removed. The 
MQP group considered filter characteristics that would satisfy the bandwidth 
requirements of our respective signals, as well minimize as the effect of signal noise.  
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4.6.3 Signal Digitization 
Software requires that signals be sample and digitized prior to processing. For LabVIEW, 
this would be implemented via National Instruments DAQ data acquisition hardware. It 
was vital to sample signals at a rate satisfying the Nyquist theorem of sampling signals 
with at least twice their maximum frequency content in order to guarantee signal 
reconstruction. It is recommended that signals used for HRV analysis be sampled at a 
frequency greater than 250Hz for proper peak detection [7].  
 
4.6.4 Signal Storage 
Storage of ECG and PPG signals was important in order to allow creation of a database 
for further signal analysis. 
 
4.6.5 Interbeat Interval Detection 
The raw data for calculating HRV are interbeat intervals obtained from either the ECG or 
PPG signals. This is usually determined from the ECG QRS complex which offers the 
advantage of having a high SNR, although artifact such as from noise or enhanced P or T 
waves can interfere with this peak detection. The MQP group anticipated the challenges 
with implementing a proper peak detection method for the PPG signal as it lacks a 
characteristic sharp peak. There is also the presence of a dicrotic notch that can introduce 
false peaks. The MQP group considered peak detection methods that would adapt itself 
for inherent differences in physiological signal amplitudes, through an adjustable 
threshold, calibrated based on incoming signal amplitudes. 
 
4.6.6 Signal Artifact Detection 
HRV algorithms require the removal of abnormal beats for proper data interpretation, as 
their introduction could render the system results invalid. The MQP group investigated 
algorithms that would be used to minimize those introduced by motion artifacts as well as 
false peaks. The MQP group determined that these could be implemented either through 
amplitude or abnormal interbeat interval rejection.  
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4.6.7 Rate and Rate Variability Algorithms 
The MQP identified that several processing algorithms would be implemented to 
calculate HR/PR. One method involved the direct averaging of interbeat intervals. Other 
methods include spectral analysis. HRV measures included rMSSD and SDNN indices 
through Equation 3 and Equation 4. Buffers are also necessary to store data values for 
these calculations. 
 
4.6.8 Heart Beat Beep and Alarm Controls 
The MQP group decided to implement audible QRS peak detection, to mimic a clinical 
device monitor. Also alarm controls were implemented to monitor patient HR within a 
certain acceptable range by using comparators.  
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Figure 4.4: Developed transparent box of device design with inputs and outputs 
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4.7 Initial Design Specifications 
The MQP group established initial device specifications to provide a basis for evaluating 
our final design. These specifications were primarily based on similar commercial 
devices, summarized in Appendix G.  
 
4.7.1 Physical Dimensions 
The hardware portion of the device needed to be portable. In an effort to better describe 
the term „portable,‟ the MQP group researched the characteristics of a few similar 
industry products for their size and weight. A range within cell phone to PDA size was 
considered to be ideal for our device. However, to allow for greater size, the maximal 
device size was set with regards to the Marquette Medical Systems Series 8500 Holter 
Monitor, an older version of portable heart monitoring device (see Appendix G). Physical 
dimensions of our device were capped at 6.00 x3.25 x1.125 inches and 10 oz weight. 
 
4.7.2 Example Industry Specifications 
4.7.2.1 PPG 
 PPG signal of at least 1V peak-to-peak amplitude 
 Bandwidth between 0.5 – 20 Hz  
 PR calculation range between 30-240 bpm 
 PR accuracy of ±5bpm between 30-150 bpm 
 Battery life greater than 6 days 
4.7.2.2 ECG 
 Standard ECG lead configuration 
 Overall signal gain of one thousand 
 HR detection range between 30-240 bpm 
 Accurate to within ±5bpm  
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5. Alternative Designs 
The MQP group generated and evaluated the best possible alternative designs for 
implementation of the project. Design alternatives were weighted with reference to the 
design objectives, developed from the set objectives in section 4.3. The MQP group 
utilized a divide and conquer approach, by breaking down the device system into 
manageable sub entities that were easier to handle. Each of the sections below details the 
different design alternatives as well as their respective relative strengths and weaknesses.  
 
5.1 PPG 
Functions of the PPG unit include extracting and conditioning PPG waveform 
appropriately prior to LabVIEW processing. It consists of a photodetection unit, bio-
amplifiers and hardware filters. The photodetection unit consists of the LED, photodiode 
and transimpedance amplifier.  
 
5.1.1 Sensor Wavelength 
The MQP group evaluated wavelengths to determine the most suitable one for our design. 
This was determined by examining the absorption spectra of blood (see Figure 5.1). The 
main pigments responsible for light absorption in blood are hemoglobin (Hb), a metallo-
protein and its oxygenated form HbO2. Red blood cells make up about half of blood 
composition and Hb within their cells is responsible for oxygen transportation [16]. The 
absorption coefficients of Hb and HbO2 differ over the range 650nm-1000nm except at 
the isobetic wavelength of around 805nm. Wavelengths shorter that 600nm are typically 
not used for PPG applications because red skin pigmentation absorbs a great amount of 
light within this range [14]. Since arterial blood contains greater concentration of HbO2, 
it is necessary to select a wavelength greater that the isobetic length where the absorbance 
of HbO2 is greater, to better capture the pulsatile PPG waveform.  
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Figure 5.1: Absorption spectra of oxygenated and deoxygenated Hb [15] 
 
Another criterion for wavelength selection is the relative flatness of the curve over the 
wavelength region. The peak emission spectra of LED‟s shift with temperature change.  
Theoretically, the peak wavelength of an LED is defined as the wavelength at which the 
radiated power is maximal, but usually the actual peak wavelength occurs over a 
bandwidth range [14]. Shifts in these peak emission spectra can pose problems in peak 
detection due to changing amplitudes resulting from different temperature conditions. 
The absorption spectra curve is relatively flat over the region of 900 to 950nm, and the 
bandwidth consideration is considered not important for accuracy due this flatness of the 
curve. An LED of peak emission wavelength of 940nm, with a low maximal power 
dissipation of 75mW (LTE-302-M) was thus selected.  
 
5.1.2 Sensor Mode 
PPG signals can be acquired by either transmittance or reflective mode. Table 5.1 
summarizes difference between the two methods. The choice of transmittance or 
reflectance was going to be determined based on the selected sensor location. 
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Table 5.1: Comparison of Transmittance and Reflectance PPG Probes  
Mode 
Transmittance Reflectance 
Factor 
Principle 
Dependent on light being transmitted 
through tissue, usually requires soft 
tissue to allow for maximal 
transmission 
Dependent on light being reflected 
from tissue,  and presence of bone 
tissue and thin skin layer facilitates 
light reflection 
Sensor Placement 
Sensor is limited to peripheral locations 
with small tissue size (e.g. ear, toe, 
nasal septum etc) 
Sensor can be placed relatively 
anywhere in the body, both internally 
and externally 
Blood Perfusion 
Peripheral locations are subject to 
vasoconstriction 
If location is close to body center, 
perfused region isn‟t too affected by 
vasoconstriction 
Motion Artifact 
Peripheral locations are susceptible to 
motion artifacts 
Motion artifacts susceptibility depends 
on sensor location 
Power 
Consumption 
High; battery life approximately 4.8 
hours[18] 
Low; battery life approximately 73.3 
hours[18] 
 
5.1.3 Sensor Location 
Sensor placement locations usually affect PPG signal quality, and site location also limits 
the mode of signal detection. In selecting the PPG sensor location, the MQP group 
considered the following factors: 
 
1. Minimize power consumption: This is necessary to extend battery life. Batteries 
typically have a specified mAh (i.e. milliamp/hour) rating and thus lower current 
usage extends battery life. For example, for a 150 mAh battery, 0.5mA and 1mA 
current use will drain the battery in 300 and 150 hours, respectively. Power 
requirement also depends on sensor location, as well as mode of signal detection. 
 
2. Area blood perfusion: System accuracy is dependent on the ability to obtain a 
high amplitude signal for processing. Highly perfused regions usually provide 
higher amplitude signal. In reflectance PPG, the presence of a bone beneath the 
perfused tissue also facilitates light reflection and thus better signal detection. 
 
3. Minimize motion artifacts: Sensor location should be less susceptible to motion 
artifacts as the system is to be used for moderate daily activity. Motion artifacts 
can further be eliminated by filtering and software processing. 
 
4. Stable sensor attachment: Sensor attachment should prevent dislocation of the 
sensor. This can be implemented by adhesives, bands or clips. 
 
5. Sensor comfort: Sensor should be small in size, as well as be familiar to the 
person wearing the device. 
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The MQP group ranked evaluated and ranked these design factors in a PCC to determine 
the level of importance in sensor location consideration: 
 
Table 5.2: Pairwise Comparison Chart for PPG Sensor Location Objectives 
 
Power 
Consumption 
Blood 
perfusion 
Sensor 
Stability 
Motion 
Artifact 
Sensor 
Size 
Total 
Score 
Normalized 
Fraction 
Power 
Consumption 
x 0 1 0 1 2(+1) 0.300 
Blood 
perfusion 
1 x 1 0.5 1 3.5(+1) 0.300 
Sensor 
Stability 
0 0 x 0 1 1(+1) 0.133 
Motion 
Artifact 
1 0.5 1 x 1 3.5(+1) 0.200 
Sensor 
comfort 
0 0 0 0 x 0(+1) 0.066 
 
The MQP group ranked blood perfusion and motion equally highest because both affect 
signal quality as well as the accuracy and reliability of software algorithms. Signal 
integrity is a very critical factor in the technical design of wearable sensors. Therefore, 
signals with higher SNR are preferred. Minimizing motion artifacts is important 
considering that the patient is going to be using the device during normal daily activity.  
 
Power consumption was ranked next among objectives because of the battery operated 
hardware. Hence, locations that minimize power requirement are preferred, as this will 
extend device battery life, reducing the problem of the user constantly changing batteries.  
 
Sensor attachment should be stable to guarantee good skin contact during signal 
acquisition and prevent dislocation that can either result in false system alarms or 
introduce additional artifacts. This can be achieved either through adhesives, sensor clips, 
or bands. Adhesives pose the problem of dislocation due to wear of the glue material, as 
well as other factors such as sweat and skin oils. Clip sensors are more susceptible to 
signal motion artifacts [14]. Alternatively, sensors can be wrapped around measurement 
area using a band with adjustable straps, thus preventing the problem of dislocation.  
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The MQP group ranked sensor comfort lowest given the precedence of clinical 
considerations in the design. In addition, sensor probes can be made small enough due to 
the relative small sizes of LED‟s and photodiodes, although some locations may prove 
uncomfortable for the user.  
 
Ranked objectives: Signal amplitude + motion artifacts > Power consumption > Sensor 
stability > Sensor comfort.  
 
Transmittance probes have enabled the placement of PPG probes in virtually any part of 
the body. CJ Pujary identified at least 20 sensor locations that have been used in research 
[18]. Given the scope and time limitation of this project, it was necessary for the MQP 
group to narrow down sensor locations to at least a few sites to facilitate design 
alternative evaluation. Sensor locations were narrowed down based on clinical 
acceptability, sensor versatility, available research data as well as user familiarity and 
comfort. Some areas in the body can also utilize both transmittance and reflective modes 
e.g. cheek, finger, palm.  
 
Four areas were primarily selected and these include: finger, ear, arm, and forehead (see 
Figure 5.2).These areas were ranked according to the five criteria developed above.  
 
The following scale was used: 
 
Motion Artifact:                      most 1 …4  least 
Blood perfusion:                      low  1 …4  high 
Power Consumption:              high  1 …4  low 
Sensor Stability:                  unstable 1 …4  stable 
Sensor comfort:           uncomfortable  1 …4   comfortable 
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Figure 5.2: PPG Sensor location alternatives [28], [46]-[47]  
 
 
Table 5.3: Numerical Evaluation Matrix for PPG Sensor Locations 
 Finger Ear Forehead Arm 
Motion artifacts  0.300*1= 0.300 0. 300*3= 0.900 0. 300*3= 0.900 0. 300*1= 0.300 
Blood perfusion 0. 300*3= 0.900 0. 300*3= 0.900 0. 300*4= 1.200 0. 300*4= 1.200 
Power 
consumption 
0.200*2= 0.400 0.200*2= 0.4000 0.200*4= 0.800 0.200*3= 0.600 
Sensor stability 0.133*3= 0.399 0.133*3= 0.399 0.133*3= 0.399 0.133*3= 0.399 
Sensor comfort 0.066*2= 0.132 0.066*2= 0.132 0.066*3= 0.198 0.066*3= 0.198 
Total 2.131 2.731 3.497 2.697 
 
Signal amplitude is generally evaluated by examining the blood perfusion (see Appendix 
H). Pujary ranked signal strength obtained from these areas as: finger base-high, ear-high, 
arm-medium and forehead-high [18]. However, Hummler et al examined the limitations 
of relying on perfusion index in selecting sensor location site, in cases with during poor 
peripheral perfusion such as during vasoconstriction or sepsis [48]. Using the perfusion 
index alone is thus not sufficient to evaluate signal accuracy. Peripheral locations are 
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most susceptible to vasoconstriction due to cold environmental conditions. The finger and 
the ear are mainly affected due to their smaller surface areas, hence ranked lower. Pälve 
assessed the performance of the transmittance and reflectance probes in compromised 
peripheral perfusion during cardiac surgery [49]. He concluded that even though the 
accuracy of pulse rate data was comparable, the reflectance sensor was more likely to 
obtain better readings under poorer peripheral circulation.  
 
Transmittance sensors generally require a larger current than reflectance probes. Due to 
the large sizes of the forehead and arm, they are limited to reflectance probe sensors. The 
ear and finger can utilize both transmittance and reflectance modes [48], [51]. Savage et 
al were able to demonstrate that reflectance finger probes had a lower current 
requirement than transmittance probes, with battery life lasting 18 times longer than the 
latter [23]. Other means to extend battery life include achieving a balance between 
increasing the photo-detection surface area, reducing the amount of current and 
decreasing the duty cycle of the LED current source [52]. Increased photodetection area 
increases the amount of backscattered light detection. However, reducing current can 
adversely affect signal quality, because of the effective reduction in the intensity of the 
transmitted signal.  
 
It was important for the MQP group to select a location that will be least susceptible to 
motion artifacts to minimize errors. Placing the sensor in limbs can limit patient mobility; 
hence the lower scores for finger and arm sensors. Fingers are even more susceptible due 
their smaller size. Johnston et al compared the effect of motion artifacts on measurement 
accuracy on forehead, jaw, chin and finger sensors [21]. Subjects were made to do a 
series of exercises such as talking, head movements and vertical motion. Signals recorded 
from the forehead demonstrated greater stability during all activities. Forehead sensors 
are also the preferred location of choice in military applications, to detect physiological 
parameters from moving soldiers [21]. By inference the ear sensor was also ranked like 
the forehead sensor.  
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Sensor attachment to measurement site should eliminate the possibility of dislocation 
under motion. The MQP ranked all sensors equally because of the possibility of using a 
variety of attachment options on the sites. 
 
The MQP ranked sensor comfort lowest in finger due to decreased user mobility. The ear 
sensor can cause swelling due to soft tissue. Forehead and arm locations are considered to 
be familiar locations to the device user.  
 
The MQP group thus selected the forehead sensor due to its low power requirement, least 
susceptibility to motion artifacts, higher signal amplitude and moderate sensor stability.  
 
5.1.4 Sensor Architecture 
Since the MQP group selected a forehead sensor probe, it was limited to either adhesive 
or band type due to its size. Both attachment methods are used in clinical settings [47]. 
Since signals were going to be acquired from the same site, the MQP group considered 
long term sensor stability as the only factor for consideration. Two design architectures 
were considered for our design (see Figure 5.3).  
 
 
Figure 5.3: Design alternatives for PPG sensor architecture 
 
 
 
A B 
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Design A: Headband Sensor 
This design consists of an open end headband sensor with an attached photodetection 
unit. The photodetection unit was shielded with a pliable plastic, and surrounded by a 
padded cushion. The ends of the sensor band are attached with Velcro of varying lengths 
for user to adjust according to head circumference.  
 
Design B: Adhesive Sensor 
This design consists of the photodiode arrangement mounted on a durable and pliable 
support. The photodetection unit was shielded with a pliable plastic, and surrounded by a 
padded cushion. Adhesives are attached to the backend of the diode support and changed 
as desired.  
 
The MQP group used standard DB9 connectors as hardware inputs, to facilitate LED and 
photodiode arrangements. The MQP group used the same LED and photodiode 
specifications to better compare signals between both sensors. As expected, signals 
obtained from both sensors were comparable. However, the adhesive sensor was more 
susceptible to dislocation due to weakening of glue, which was facilitated by sweating as 
well as skin oils, thus requiring constant replacements. The MQP group determined that 
this might not be suitable for long term monitoring and constant adhesive replacement 
can also affect long term device cost. Dresher compared errors obtained from forehead 
sensors with elastic band, helmet and adhesive attachments under motion [53]. The tests 
confirmed a statistical difference in PR measurements between attachment methods, with 
band sensors offering lesser error than adhesive type sensors.  
 
The MQP group selected the forehead band sensor due to its greater long term stability, 
guarantying good surface contact for signal acquisition. 
 
5.1.5 Filters 
Filter functions include extracting and amplifying the AC component of the PPG signal, 
eliminating noise such DC component, baseline drift and 60 Hz noise. Filters have to 
fulfill the bandwidth requirement of the PPG waveform. The PPG signal is very similar 
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to that of blood pressure waveform, which can be reproduced with up to the tenth 
harmonic. The MQP group determined that filtering could either be implemented via 
hardware or software. In selecting filter type the following design factors were 
considered: 
 
1. Minimize cost: Software filtering was readily available in the computer via 
LabVIEW. Reducing number of IC components in hardware will minimize mass 
production costs. 
 
2. Flexibility: Filtering methods should be flexible to change characteristics like 
filter bandwidth, order, type etc. 
 
3. Effectiveness: This is determined by its ability to meet its bandwidth 
specifications and eliminate noise. 
 
 
The MQP group evaluated these factors in a PCC to determine their level of importance: 
 
Table 5.4: Pairwise Comparison Chart for PPG Filter 
 Cost Flexibility Effectiveness Total score Normalized 
fraction 
Cost x 0 0 0(+1) 0.167 
Flexibility 1 x 0 1(+1) 0.333 
Effectiveness 1 1 x 2(+1) 0.500 
 
The MQP group ranked filter effectiveness highest because the ability to accurately 
determine PR is greatly dependent on the filter meeting its bandwidth requirement and 
eliminating the necessary noise. Flexibility to change filter parameters was considered for 
the design implementation to allow the testing of a variety of options design under 
minimal time. Device cost was ranked least because of the precedence of filter 
effectiveness on signal accuracy as well as the flexibility of the designer to change 
parameters during the design process under limited time. The MQP group evaluated both 
filtering methods in a numerical evaluation matrix, using the following nominal scale: 
 
Effectiveness:                   High (1), Low (0) 
Flexible:                            Yes (1),   No (0) 
Mass production cost:       High (1), Low (0) 
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Table 5.5: Numerical Evaluation Matrix for PPG Filter Design 
 Hardware Software 
Effectiveness 0.500*0.0=0 0.500*1.0=0.500 
Flexible 0.333*0.0=0 0.333*1.0=0.330 
Cost 0.167*0.0=0 0.167*1.0=0.167 
Total 0 1 
 
Software filtering utilizes digital filters which can be designed to fulfill its bandwidth 
requirements, with lesser degree of error hence ranked higher. The effectiveness of 
hardware filtering is greatly dependent on the tolerance values of filter components 
(resistors, capacitors, etc). These can be purchased in various tolerance ranges (1%, 5% 
10%) with per unit cost increasing with decrease in tolerance values. However, active 
hardware filters can introduce additional noise like bias voltage as well as changing filter 
characteristics due to temperature. In addition, there is the likelihood of component 
failure. 
 
Software filtering offers the advantage of being able to change filter parameters in a short 
time. LabVIEW software also has the option of changing filter type (Butterworth, 
Chebyshev etc). Software filtering is also programmable, can be designed, tested and 
implemented within a short time period, with greater versatility of implementing robust 
algorithms. Changing parameters in hardware requires physically changing components 
which can be time consuming. This can pose a problem especially in an already finished 
product should errors occur.  
 
Although the initial cost of software is expensive, a one-time purchase can be 
downloadable to several units. However, it requires an analog to digital converter prior to 
signal processing. Mass production can reduce hardware component cost due to 
discounted low per unit cost, thus minimizing the number of components reduces overall 
device cost. However, cost can significantly be larger depending on the number of device 
units. 
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The MQP group implemented software filtering for PPG signal to satisfy the bandwidth 
requirement of the PPG signal. In general, the PPG waveform is similar to the blood 
pressure waveform which can be reproduced with as much as its 10
th
 harmonic. For an 
average HR of 60bpm, i.e. 1Hz, the high cut off for this filter can be about 10Hz. To 
eliminate DC and baseline drift, the MQP group selected a low cut off of 0.5Hz. The 
MQP group selected a Butterworth filter because of its flat gain characteristics, and its 
steep roll off which could be achieved with higher filter order. However, an order of 3 
was selected because greater filter settle time was observed in filters of higher order. The 
MQP group implemented a 3
rd
 order Butterworth filter with bandwidth of 0.5-10Hz 
directly after the transimpedance amplifier stage. However, the resulting signal was very 
noisy (see Figure 5.4).  
 
 
Figure 5.4: PPG signal obtained after LabVIEW software filtering 
 
The MQP group explored several other options like increasing filter order, or changing 
filter type, and no change was observed in signal quality. Due to time limitation in 
exploring other software functions, the MQP group decided to pursue the option of 
implementing hardware filtering prior to LabVIEW, with additional filtering 
implemented via software. Signals pre-filtered with hardware were observed be of better 
quality (see Figure 5.5). Initial testing for component values were implemented first on a 
breadboard until component values were finalized prior to soldering unto a printed circuit 
board. 
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Figure 5.5: Clean PPG signal after pre-hardware filtering 
 
5.2 ECG 
Objectives for the ECG portion of the project were to develop an effective method for 
acquiring the ECG signal, applying basic filtering, and sending the signal to the software 
for further analysis and display. This section of the project consists specifically of a 
standard instrumentation amplifier, connected to the body through experimental dry 
electrodes, and sent through to the software following basic analog hardware filtering.  
 
5.2.1 ECG Electrodes 
The electrodes for the ECG system are a primary design consideration. The objective of 
the project was to develop and implement dry electrodes for the ECG monitor. This was 
done to allow for continuous use of the electrodes without the possibilities of electrode 
fouling due to drying of the electrode gel or skin irritation. With regards to the electrodes, 
three alternatives were tested for compliance with the design criteria. These alternatives 
were the use of stainless steel plates, silver/silver chloride contact, and silver/silver 
chloride contact with vinyl adhesive. The stainless steel plates were circular stainless 
steel metal contacts, approximately one inch in diameter. These plats were secured to the 
body via medical tape and connected into the circuit for analysis. Both of the silver/silver 
chloride electrodes were developed from standard gel-based electrodes. An example of 
the gel-based electrodes used is shown in Figure 5.6a, with an example of the dry 
electrode shown in Figure 5.6b. This design was divided into two parts, one retaining the 
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vinyl adhesive, the other with the adhesive removed to ensure that signal acquisition was 
done only through the metal contact surfaces, with the adhesive having no affect on the 
signal quality or strength.  
 
 
Figure 5.6: Wet (a) and dry (b) ECG electrodes  
 
Each design was capable of acquiring the signal to varying degrees. The results of testing 
for each of the electrodes can be found in Appendix F. Design evaluation criteria for the 
electrodes were as follows: 
 
1. Signal Quality: depending on the chosen electrode type, there are degrees of 
baseline noise inherent to the electrode. The optimal design alternative should 
minimize this potential noise artifact.  
 
2. Electrode Motion Artifact: depending on the electrode choice, there is the 
possibility for physical motion of the electrode. Should this occur, significant 
amounts of noise will enter the system due to the capacitive coupling between the 
skin and electrode surface [11].  
 
3. Ease of Use: depending on the electrode alternative, varying degrees of attention 
is required for the use of the electrode. Should the electrode not in itself include a 
method for adhering to the body, additional methods for doing so would be 
required by the user.  
 
4. Reliability: depending on the electrode alternative, the reliability of the chosen 
method can vary. This may be particularly evident with the stainless steel plates 
as variations between the sensors would prevent consistent data acquisition 
between tests.  
 
(a) (b) 
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Table 5.6: Pairwise Comparison Chart for ECG Electrode Type 
 
Signal 
Quality 
Motion 
Artifact 
Ease of Use Reliability Total Score 
Normalized 
Fraction 
Signal 
Quality 
x 1 1 1 3(+1) 0.40 
Motion 
Artifact 
0 x 1 1 2(+1) 0.30 
Ease of Use 0 0 x 1 1(+1) 0.20 
Reliability 0 0 0 x 0(+1) 0.10 
 
Of the given criteria, signal quality was the most important factor in determination of the 
appropriate electrode alternative. Without a sufficient signal quality, analysis of the 
signal is not possible. Should the quality be inherently poor with a certain design 
alternative, than that design would be an inappropriate choice. Each of the design 
alternatives was ranked to determine the overall effectiveness of each design. Rankings 
of the alternatives ranges from one to three, depending on how well the alternatives meet 
the criteria set forth.  
 
Table 5.7: Numerical Evaluation Matrix for ECG Electrode Type 
 
Stainless Steel 
Plates 
Ag/AgCl w/o 
Adhesive 
Ag/AgCl w/ 
Adhesive 
Signal quality 0.4*1 0.4*2 0.4*3 
Motion Artifact 0.3*1 0.3*1 0.3*3 
Ease of Use 0.2*1 0.2*1 0.2*3 
Reliability 0.1*1 0.1*2 0.1*3 
Total 1 1.5 3 
 
For the tests performed on the different electrode alternatives, the silver/silver chloride 
electrodes with the surrounding adhesive performed the best. This greater performance 
than the other alternative designs allowed for a greater signal quality and most 
significantly a reduction in the possibility for electrode sensor movement due to the 
incorporation of the contact adhesive with the electrode sensor face. The results of the 
tests performed can be seen in Appendix F.  
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5.2.2 ECG Electrode Location 
There were two primary alternative designs considerations for the ECG sensor location. 
Possible placements for electrodes were either on the extremities or on the chest. The 
following criteria were used to determine the relative effectiveness of each sensor 
location: 
 
1. EMG Motion Artifact: Depending on the locations of the electrodes, greater or 
lesser degrees of motion artifacts may be present. This is primarily depending on 
the amount of muscles between the sensors, where greater amounts will have the 
ability to create a greater voltage potential. 
 
2. Signal Strength: Depending on the proximity to the heart, the signals will have 
varying amplitudes. This is due to the differences in effective resistance that 
increasing degrees of tissue will cause.  
 
3. Electrode Lead Length: Depending on the placement of the electrodes, greater or 
lesser degrees of wire is needed to make the connections between the electrodes 
and the hardware sensing suite.  
 
Table 5.8: Pairwise Comparison Chart for ECG Sensor Placement  
 
Motion 
Artifact 
Signal 
Strength 
Lead 
Length 
Total 
score 
Normaliz
ed 
fraction 
Motion 
Artifact 
x 1 1 2(+1) 0.500 
Signal 
Strength 
0 x 1 1(+1) 0.333 
Lead Length 0 0 x 0(+1) 0.167 
 
From the criteria, it was determined that motion artifacts due to EMG signals were the 
most influential in determining the appropriate lead placement. This was determined 
since of the listed criteria, the motion artifacts were the only criterion that would prevent 
the signal from being properly analyzed. Signal strength could be compensated for by 
increasing the overall gain of the system, and lead length does not have a direct affect on 
the signal quality, only on the overall ease of use of the system. For ranking of the 
different alternatives, each was ranked in relation to the listed criteria. Values were given 
based on a scale of zero and one, where the design alternative that better attained the 
criteria was ranked higher. Equal attainment of a given criteria results in an equal 
ranking.  
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Table 5.9: Numerical Evaluation Matrix for ECG Sensor Placement  
 Chest Extremities 
Motion Artifact 0.500*1 0.500*0 
Signal Strength 0.333*1 0.333*0 
Lead Length 0.167*1 0.167*0 
Total 1 0 
 
Following analysis of the two design alternatives, it was determined that the chest 
placement of the electrodes outperformed placement on the extremities. Placement on the 
chest allows for a reduction in the overall motion artifacts since there is a lesser degree of 
muscle activity occurring between the two electrodes. As such, the amplitude of EMG 
signals detected will be lesser. Furthermore, since the chest electrodes are anatomically 
closer to the heart, the overall strength of the signal is increased. Finally the lead length is 
reduced since there is a lesser amount of spacing between each of the three electrodes. 
This allows for the sensing hardware to be placed closer to each of the electrodes, 
reducing the necessary lead length. A comparison of the two signals can be seen in Figure 
5.7, where the electrodes placed on the chest have greater overall amplitude and a slightly 
lower baseline noise.  
 
Chest versus Extremity Electrode Placement
Chest Extermities
 
Figure 5.7: Chest versus extremity electrode placement  
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5.2.3 Filters 
There were two main design alternatives considered for the filter portions of the ECG 
hardware. These alternatives were to condition the signal entirely with the use of analog 
hardware filters or to employ the use of software filters for the primary filtration of the 
signal. For this portion of the project, the two implementations of the design can be seen 
as Revision A and Revision C in Appendix B. Revision A is comprised of a single analog 
hardware filter. Its purpose is to prevent baseline drift of the signal, which is especially 
important for preventing signal saturation of the operational amplifiers. Revision C 
consists of full hardware filtration of the ECG signal. Design criteria established was 
used to evaluate the relative advantages and disadvantages of the filter alternatives. The 
following design criteria were used to evaluate the effectiveness of the ECG hardware 
filter alternatives:  
 
1. Cost: Lowering the costs of the individual units will allow for greater production 
and lesser unit costs.  
 
2. Reliability: Reductions in the total number of hardware components allows for 
increases in the overall reliability as there are fewer possible components that may 
fail during use.  
 
3. Effectiveness: The filters must have sufficient effectiveness in order to provide 
the user with the expected signal outputs.  
 
Table 5.10: Pairwise Comparison Chart for ECG Filter Design 
 Cost Reliability Effectiveness 
Total 
score 
Normalized 
fraction 
Cost x 0 0 0(+1) 0.167 
Reliability 1 x 0 1(+1) 0.333 
Effectiveness 1 1 x 2(+1) 0.500 
 
For the given criteria, the effectiveness of the design ranked highest. Without the ability 
to provide the user with the desired signal, the design would not be appropriate. 
Following this, the reliability of the device is ranked second with the overall device 
determined to have the least overall effect on the decision process. The ability of the two 
alternatives to meet the design criteria was determined based on a scale of zero to one. 
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The design alternative that better met the described criteria was ranked higher as one. The 
values from each were totaled then to determine the better alternative.  
 
Table 5.11: Numerical Evaluation Matrix for ECG Filter Design 
 Hardware Software 
Effectiveness 0.500*0 0.500*1 
Reliability 0.333*0 0.333*1 
Cost 0.167*0 
0.167*1 
Total 0 1 
 
It was determined that the software filtering design was most capable of performing the 
requisite functions. Being that there were only a limited number of hardware components 
used to initially condition the signal, the reliability of the total design is increased due to 
lower possibilities for component failure. The effectiveness of the total design is 
furthermore increased primarily due to the ability to fine-tune the frequency ranges of the 
software. Utilizing a smaller bandwidth of frequencies, it is possible to disallow 
additional artifacts that would not be possible with the hardware filters. Finally the 
overall cost is reduced by limiting the necessary components of the design.  
 
5.3 Software Algorithms 
One of the software functions is to implement algorithms for both rate and variability 
index calculations. Of interest are HR/PR as well as R-R time intervals. The algorithm 
choice was based on its effectiveness in implementing the desired function.  
 
5.3.1 R-R Interval Detection 
R-R time intervals were necessary for calculation of SDNN and rMSSD indices, by 
detecting peaks of ECG and PPG waveforms (see Equation 3 and Equation 4). Two 
methods were used to determine these intervals. Signal algorithms were investigated by 
inputting signals of known frequencies into the system, and comparing the observed time 
interval value with its ideal.  
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5.3.1.1 Peak Time Location 
In this method, the R-R interval time between consecutive peaks is calculated by taking 
the time difference between peak occurrences. When peaks are detected, the locations are 
given with respect to the block of data being analyzed (see Figure 5.8). As such, raw 
location outputs are represented as a number between zero and one hundred. Time 
between peaks is determined by determining the peak locations with reference to the total 
acquisition and subtracting the previous location from the current. This total number is 
multiplied by the inverse of the sampling rate of the software to determine the overall 
time between peaks. 
  
 
Figure 5.8: Time peak locations 
 
5.3.1.2 Elapsed Time 
In this method, the R-R interval time between consecutive peaks is calculated by 
initiating a timer each time a peak is detected. When a peak occurs, a binary 1 is 
displayed, and 0 if otherwise. The binary 1 initiates the timer to start measuring elapsed 
time. The timer is reset each time a new peak is detected, and the value of elapsed time 
stored in a buffer.  
 
 
Figure 5.9: Peak detection via timer  
 
Of the two design alternatives analyzed, it was determined that peak location was the 
better method. This was based on the fact that the program could not reliably detect the 
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location of the peak when used for timing between the peaks. This was due to the nature 
of the software and it‟s method for analyzing data. The software portion of the program 
acquired data continuously at a 1000Hz sampling rate, and analyzed the data in blocks of 
100 samples. Because of this, the elapsed timer was capable only of determining the 
locations of peaks to within a tenth of a second. This resolution would not have been 
capable of properly analyzing data.  
 
5.3.2 Heart / Pulse Rate Calculation 
Two signal processing algorithms were investigated for measuring rates. These included 
rates calculated from a sequence of R-R intervals and via frequency analysis of the 
signal. Rate averaging was used for the ECG signal. Both methods were investigated in 
the PPG signal.  
 
5.3.2.1 Rate Averaging 
This algorithm was implemented by calculating the average value of a number of 
consecutive R-R time interval values. The R-R interval values are stored in a buffer as 
milliseconds between peaks. The inverse of this average was multiplied by 60,000 to 
obtain rate in beats per minute (see Figure 5.10).  
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Figure 5.10: HR averaging 
 
5.3.2.2 Frequency Analysis 
This method calculated PR based on the spectral analysis of the blocks of the PPG signal. 
The largest amplitude frequency content corresponded to the fundamental frequency of 
the signal. This fundamental frequency was then multiplied by 60 to give PR. 
 
 
Figure 5.11: PR by frequency analysis 
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5.4 User Interface 
In designing the user interface, it is essential to meet user expectations by communicating 
the data accurately and clearly as well as meeting regulatory requirements for clinical 
acceptance. In particular, the US Food and Drug Administration Guidance for Pulse 
Oximeters and Diagnostic ECG as well as the Standard Specifications for Pulse 
Oximeters, F1415-1992 from the  American Society for Testing and Materials (ASTM) 
[14]. FDA standards include regulatory requirements as well as recommended device 
testing and documentation for submitting 510(k) for device approval in the US. ASTM 
standards are international specification and testing requirements that globally harmonize 
the quality of medical equipment. While data accuracy is addressed in the core aspect of 
the device design, clarity of data communication involves displaying the necessary 
information in a useful way to the device user. The desired outputs of the system include 
real time graphical displays of ECG and PPG physiological signals as well as computed 
HR/PR, rMSSD and SDNN HRV/PRV indices. Also necessary for this application are 
alarms that alert the user of specific activities e.g. acoustic alarms to indicate instances of 
heartbeat, or audio-visual alarms to indicate low or high heart rate. Function controls 
include the on and off switch, as well as alarm controls to indicate low and high heart 
rate. The ASTM standard requires that alarm controls be operator adjustable. Data 
storage and easy retrieval protocol is also useful a useful tool for further signal analysis, 
for better patient care.  
 
5.4.1 Layout 
Several commercial heart/PR monitors were reviewed in designing a familiar user 
interface layout. In designing the layout, it is essential that the layout of the graphical 
displays, indicators and controls have a relationship. In most multi-signal monitors there 
are generally two types of relationships: vertical and horizontal. Horizontal relationships 
display data from obtained from the same physiological signal, while vertical 
relationships display similar data from different types of signals as can be seen in Figure 
5.12. While the overall aesthetic between devices may be different, design outputs are 
generally displayed in a similar manner, for easy harmonization amongst healthcare 
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users. The user interface would thus implement the same basic layout for data 
communication.  
 
 
Figure 5.12: Sample industry monitor by Mindray PM 7000 [54] 
 
Graphic displays 
Visual Alarm 
Numeric displays 
Function Controls 
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6. Methods 
6.1 PPG 
6.1.1 Photodetection Unit 
The photodetection unit consists of the standard photo-emitter photo diode circuit 
coupled with a transimpedance amplifier (see Figure 6.1). The MQP group selected an 
LED diode with a peak emission wavelength of 950nm (LTE), and also with a 
photodiode with a peak wavelength sensitivity of 940nm (QSB34ZR). The MQP group 
measured a 1.2V drop across the IR LED diode, to take into consideration when 
calculating our current values for the LED drive current. 
 
IC 1A
IR LED
RG
Transimpedance 
amplifier
-
+
V
+
V
-
R
iD
Photodiode
id
Vout
 
Figure 6.1: Light emission and detection circuit 
 
The IR LED emits light with intensity proportional to the amount of current, iD, through 
it. The photodiode generates an output current, id, proportional to the intensity of 
reflected light. The transimpedance amplifier converts the current to an output voltage, 
(see Equation 5). The generated current is usually very small, and so the gain resistor, RG, 
is typically in the MΩ range. 
 
 Gdout RiV   (5) 
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Initially, the MQP project group thought that a differential transimpedance amplifier 
would more effective in collecting PPG signals, shown in Figure 6.2.  
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Figure 6.2: Differential transimpedance amplifier 
 
However, there was the disadvantage of additional device components. A single 
transimpedance amplifier with increased feedback resistance proved as effective, and was 
thus selected, shown in Figure 6.3. For our initial tests, a current of value iD was chosen at 
≈ 40mA, and a gain resistor of 5MΩ was chosen, though these were not the final values 
selected. 
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Figure 6.3: Single op-amp transimpedance amplifier 
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Figure 6.4: Quad op-amp pin specification 
 
6.1.2 Filter Design 
 
The MQP group designed filters to satisfy the bandwidth requirement of the PPG signal. 
The MQP group performed preliminary Fourier analysis of the PPG waveform, and 
realized it could be reproduced with as little as its third or fourth harmonic (see Figure 
6.5). For an average HR of 60bpm, i.e. 1Hz, the bandwidth of the filter can be about 3Hz. 
A high cut of 10 Hz will thus be sufficient to accommodate HR up to about 240bpm To 
eliminate DC as well as baseline drift e.g due to breathing, a low cut off frequency of 0.5 
Hz was selected.  
 
 
 
Figure 6.5: Fourier analysis of a PPG waveform 
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The MQP group thus constructed a hardware band-pass (BPF) filter (BW:  0.5 to 10Hz) 
with an overall gain of ≈ 150 by cascading high-pass (HPF) and low-pass (LPF) filters 
instead of a single op-amp BPF filter (see Figure 6.6). This was necessary to achieve a 
low gain in the high pass stage (gain = 4) to avoid saturating the op-amp with the high 
DC component from the photodiode. The MQP group calculated component values based 
on Equation 6, and selected the closest possible standard values. The MQP group 
implemented bias resistors, Rb in respective filter stages (i.e. Rb 
if
if
RR
RR


*
) to minimize 
the effect of bias current of the filter.  
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Figure 6.6: PPG band-pass filter 
 
 
 
CR
f
**2
1

  (6) 
                                  
 Where: f = cut off frequency (Hertz: Hz) 
  R = resistance (ohm: Ω) 
  C = capacitance (farad: F) 
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Table 6.1: PPG Filter Characteristics 
 fc Ri C Rf Rbias Gain 
High-pass 0.5 Hz 30kΩ 10µF 120kΩ 24kΩ 4 
Low-pass 10 Hz 3 kΩ 0.1µF 160kΩ 2.7kΩ 37.2 
Band-pass Filter bandwidth: 0.5-10Hz 148.8 
 
6.1.3 Power Optimization 
The MQP group explored options of minimizing power consumption via reduction of 
LED drive current and duty cycle. To obtain the minimum current requirement that could 
still produce an adequate waveform, the MQP group decreased the amount of circuit 
current and measured its effect on signal amplitude and quality. 
 
The MQP group implemented a pulsatile current source using an LM555 timer (see 
Figure 6.7. The duty cycle (δ) of the power supply is dictated by RA and RB resistor 
values (see Equation 7). TH represents the time when the voltage is at maximum, while 
TL, the time when the voltage is at 0V. The MQP group made TH and TL values 
independent by putting a diode across RB. The MQP group used a sample-hold IC after 
the transimpedance amplifier stage to keep voltage values constant during times when the 
LED is off.  
 
               
Figure 6.7: LM 555 timer circuit outputting 5V pulsatile 
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
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2ln** 2CRT AH   
 
2ln** 2CRT LH   
 
Due to increased noise as a result of signal sampling, the MQP group implemented an 
additional second order LPF stage. Signals at various test points in the circuit were 
observed to verify proper functioning of the PPG sample hold circuit (see Appendix F). 
To determine the duty cycle that would be optimal for our device, the MQP group 
observed the effect of various duty cycle percentages on signal quality. The average root 
mean square value of the current was approximated to 0.01 δ*current at DC. This was 
done by using a pulsatile voltage from a power supply source. 
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Figure 6.8: PPG circuit to investigate current amplitude 
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6.2 ECG 
The final circuit design, shown in Appendix B as Revision A, consists of a standard 
instrumentation amplifier. Each of the two stages for this is set with a gain of 5. From 
that section, the signal filtered through the analog hardware filter described in 6.2.2, and 
has a gain of 5. The resulting total gain of the ECG hardware is 125.  
 
6.2.1 Electrodes 
The final design of the electrodes, shown in Figure 6.28, gives the design of the dry 
electrodes used for testing and experimentation. These electrodes are derived from 
VerMed‟s standard gel-based electrodes. Prior to use, the sponge and gel contained 
within were removed from the contact plate of the electrode. The contact plate was 
cleaned to ensure that there remained no residual gel. This allowed for the use of the 
metal contact plate with the surrounding adhesive to secure the electrode in place. By 
using this design, physical movement of the electrodes could be eliminated, providing a 
stable base for the contacts.  
 
6.2.2 Filter Design 
Hardware filtering was implemented through a HPF to remove baseline drift in order to 
avoid saturating the amplifier op-amps (see Figure 6.9). Removal of higher frequency 
components such as 60Hz electrical noise will be effectuated via software filtering. 
Component values were calculated based on Equation 6. 
 
 
Figure 6.9: ECG high-pass filter design  
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Table 6.2: ECG Filter Characteristics 
 RH CH fc 
High-Pass 
Filter 
75 KΩ 10 μF 0.21 Hz 
 
6.3 Software 
Signals were sampled and digitized using LabVIEW DAQ Assistant, with analog inputs 
collected via a National Instrument‟s Data Acquisition Board with a sampling frequency 
of 100Hz. Functions of the software include additional signal filtering, peak detection, 
and signal conditioning to calculate HR/PR and respective SDNN and rMSSD indices. 
LabVIEW also has to display signal waveforms and their respective calculated measures, 
as well as effectuate device controls. Details of the sequence of software processes 
applicable to both signals are summarized in Figure 6.10. 
 
 
Figure 6.10: Software flow chart  
 
The breakdown of each category will be further described in the following sections, via 
LabVIEW subVI programs.  
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Figure 6.11: LabVIEW program block diagram 
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6.3.1 Signal Acquisition 
Signal acquisition was done through the LabVIEW DAQ Assistant, with analog signals 
collected via NI DAQ board. Signal selectors were used to separate waveforms from their 
respective channels (see Figure 6.12). ECG and PPG signals were designated to channel 
0 and channel 1 respectively in the DAQ Assistant since both signals were going to be 
processed differently.  
 
 
Figure 6.12: Signal acquisition and A/D conversion 
 
6.3.2 Signal Filtering 
Software filtering was implemented to remove residual signal noise, following hardware 
filtering. Shown in Figure 6.14 are filter VI locations for PPG and ECG signals. For the 
ECG, the filter bandwidth was set to 1Hz-35Hz to accommodate for the higher frequency 
components of the QRS complex. The signal was further amplified by a gain of 8 to 
achieve a total signal amplification of 1000 (125 from the hardware). The PPG signal 
bandwidth was set to 0.8Hz-8Hz. The signal was further amplified by a gain of seven to 
achieve a total signal amplification of approximately 1050 (148.8 from the hardware). 
Filter characteristics setting can be seen in Figure 6.13. Signals were displayed in the 
front panel after filtering. 
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Figure 6.13: ECG (top) and PPG (bottom) software filter settings 
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Figure 6.14: Signal filtering and gain 
 
A further consideration for the PPG waveform is that it lacks the characteristic sharp 
demarcation in its waveform like that of the high amplitude QRS peak of the ECG 
waveform and so peak detection may not always be implemented effectively. The signal 
required a larger peak detection window. However, a dicrotic notch can introduce an 
additional peak, causing the detection of multiple peaks. Since the PPG slope changes in 
polarity from peak-to-peak, a derivative filter was used to obtain a steeper signal peak 
and separate amplitudes due to the dicrotic notch. This phase of the signal conditioning 
was done following the filtering of the signal and prior to the signal being sent through 
the remainder of the system to determine the signal peaks.  
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Figure 6.15: Sample PPG signal (a) and respective derivative (b)  
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6.3.3 Peak Detection 
Peak detection was implemented to respective signals with an adjustable threshold 
detector. In real time, blocks of data were analyzed in a peak detection window to 
determine the maximum point greater than the threshold (see Figure 6.16). This allows 
the program to ignore erroneous artifacts present such as baseline noise or other peaks 
such as the P and T waves of the ECG signal. Each block of data consisted of 100 data 
points from the acquired signal. When a peak was detected, the location of the peak 
within the 100 samples was output. Following the determination of the point within the 
total, the total number of points input to the system was added to the peak location. The 
output of this addition gave the peak location with reference to the total signal acquired. 
Times between peaks were then calculated from this, as can be seen in Section 6.3.4.  
 
 
Figure 6.16: Signal peak detection 
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6.3.3.1 Threshold Adjustment 
Adjustable threshold detection was necessary to account for the physiological variation of 
signal amplitude between individuals. Signals acquired from the same person can also 
vary depending on sensor placement. For the ECG, this was to account for factors such as 
skin resistance and electrode distance from the heart which can affect the overall peak 
amplitude. For the PPG, signal amplitude is affected by blood perfusion as well as bone 
density in signal reflection. Baseline drift due to breathing cycle also contributes to 
change in signal amplitude. Motion artifacts can also introduce additional peaks in the 
signal, resulting in abnormally high peak-to-peak time intervals. Both signals utilized 
similar methods for threshold calibration. When a peak is detected, its amplitude is 
recorded and sent to a 'for loop' for processing, and it re-executes each time a new value 
is received. This allows for the loop to act as a buffer to store a set of 5 consecutive peak 
amplitudes. Average amplitude of the 5 consecutive peaks is calculated and scaled to half 
its value and set as the new signal threshold. 
 
Analysis of various ECG recordings from different individuals showed generally little 
change in ECG beat-to-beat amplitudes over time within the same individual. The above 
described method of 5 peak amplitude average was thus sufficient to implement the 
calibrated threshold (see Figure 6.17). 
 
 
Figure 6.17: ECG threshold adjust 
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The PPG signal demonstrated greater peak-to-peak amplitude variability, especially due 
to possible baseline drift introduced from breathing as well as sensor movement. 
Erroneously high peak amplitudes introduced into the system can set the threshold 
average sufficiently high that detection of further peaks is not possible. To account for 
this error, a PPG threshold adjustment feedback was implemented by comparing newly 
calculated threshold value to previous values. The new threshold value would have to be 
within ±5% of the previous value, or else it is rejected. As such, slow growths of the peak 
amplitude are acceptable, whereas sudden jumps in the peak values would be rejected 
(see Figure 6.18).  
 
 
Figure 6.18: PPG threshold adjust 
 
6.3.4 Peak-to-Peak Interval Calculation 
As described in Section 6.3.3, peaks detected are output as their locations in milliseconds 
with respect to the total signal acquired. In order to determine the time between peaks, 
the previous peak time must be subtracted from the current. This was accomplished 
through utilizing shift registers to store the last data value and perform operations on the 
time locations (see Figure 6.19).  
 
 
Figure 6.19: Peak-to-peak timer 
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6.3.5 Time Interval Error Correction 
Following the determination of the time between peaks, it was necessary to analyze the 
times for possible anomalies. These included two possible problems; missing a beat and 
causing an abnormally high interval, or recording multiple false beats and causing an 
abnormally low interval. In order to prevent the propagation of incorrect values, 
comparators were used to correlate the present interval value with the previous. The 
current value had to be within 80% to 175% of the previous value. If not, this value was 
rejected and not propagated further into the system. Figure 6.20 shows an example of the 
signal error correction VI‟s used for both signals.  
 
 
Figure 6.20: Example signal error elimination block diagram 
 
A final component of the ECG and PPG conditioning subVIs are the iterations counters, 
which count the number of peaks detected. This portion of the subVI counts up to 8 as 
peaks are detected, and then generates Boolean true value on the 8
th
 beat and resets. This 
signal indicator is used to update the subVIs that calculates respective rates and 
variability indices, as further detailed in Section 6.3.6.  
6.3.6 Rate and Variability Calculations 
The series of interbeat time intervals are used to calculate the numeric outputs; HR, PR, 
SDNN and rMSSD indices for the respective signals. This was achieved through different 
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„for loops‟ in the subVI, as can be seen in Figure 6.21. The algorithms are applicable for 
both ECG and PPG signals. 
 
This first „for loop‟, shown in Figure 6.21a, calculates HR. Three types of HRs can be 
determined by changing buffer sizes; instantaneous HR, a 5-beat average or an 8-beat 
average. These are some averaging methods used in various commercial devices (see 
Appendix G). The number of beat intervals averaged can be altered by selectively 
choosing the number of shift registers used to compute the average. The device user can 
thus control this through an averaging control in the front panel. The default setting is 
however set to an 8-beat average.  
 
The second „for loop‟, shown in Figure 6.21b, calculates the standard deviation between 
the normal-to-normal peaks (SDNN) index, calculated using Equation 3. Points were 
saved within a buffer, implemented via shift registers. The buffer was updated each time 
a set of 8 time intervals were obtained, to avoid overlapping, ensuring each data value 
within the buffer is a unique value. A secondary analysis implemented within this portion 
of the subVI is to determine HR trend. This was implemented by comparing the average 
from a current set of 8 time values to previous set. The difference between the values is 
then determined and displayed graphically to the user to indicate whether the HR is rising 
or falling.  
 
The third and fourth „for loop‟, shown in Figure 6.21c and Figure 6.21d, calculates the 
root mean squared of the successive differences (rMSSD) index using Equation 4. This 
was accomplished by using 2 sets of for loops. “For loop” c calculates the difference 
between interbeat time intervals. “For loop” d performs the rest of the mathematical 
computation using Equation 4.  
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Figure 6.21: HR and HRV calculations 
 
Usually, the SDNN and rMSSD indices are calculated for a period of five minutes. 
However, a varying window was implemented to allow for various lengths of time 
analysis. SDNN and rMSSD indices can be calculated for thirty seconds, one minute or 
(a) (b) 
(d) 
(c) 
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five minutes, depending on device user settings. This, like the system for determining the 
averaging length, was done by selectively choosing the number of shift registers used in 
calculation of the respective equations. Also, calculated indices do not display until their 
respective buffers are full. To avoid user impatience, buffer indicators were implemented 
to show the percentages with which respective buffers were full. This was necessary 
especially due to some level of impatience that can result for long wait times encountered 
with 5 minute calculations.  
 
6.3.7 Audible and Visual Alerts and Alarms 
Audible and visual cues were used to alert the device user of specific events or potential 
problems either physiological or software related. These may indicate situations that 
require user intervention.  
 
6.3.7.1 Heart and Pulse Rate Alarm 
HR alarm controls are necessary to communicate critical information to the physician 
about the patient. Applicable for this system are high and low alarm controls. The ASTM 
Standard requires that all alarms be user adjustable, since these values may vary 
depending on individual patient [14]. HR and PR values are constantly compared to 
preset alarm thresholds. A condition loop is used to allow for monitoring of either both 
signals, or only one signal, as selected by the user. A PR or HR value not within preset 
range activates an alarm LED in the front panel.  
 
 
Figure 6.22: High/Low HR and PR alarm 
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6.3.7.2 System Fault Alarm 
As indicated in Section 6.3.3.1 an adjustable threshold system was implemented. This 
section of the program determines whether a fault has occurred from not properly 
detecting the signal peaks. Inputs for this are the last peak locations of the ECG and PPG 
signals. Should the system time increase above 3 seconds since the last peak detected, the 
program determines that a fault has occurred. When detected, the program provides for 
visual cues to alert the user and attempts to automatically correct for the problem by 
fixing the detection threshold value.  
 
 
Figure 6.23: Signal fault detection 
 
6.3.7.3 Heart Beat Alert 
QRS detection beeps are also used in clinical monitoring devices to indicate heart beat 
occurrence. An audible indicator was used to indicate peak occurrences in the ECG 
signal. A mute button was implemented to turn the beep ON or OFF as desired by the 
user. 
 
 
Figure 6.24: ECG audible peak indicator 
 
6.3.8 Signal Storage 
Data storage was also implemented for further signal analysis. These included ECG and 
PPG signal waveforms, as well as their respective interbeat interval time values. Each 
time that the program is run, a “Select a file to save” window was used to prompt the user 
to record a file name (see Figure 6.25). All files are by default to be saved to the 
computer desktop. 
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Figure 6.25: Waveform file name window 
 
The data of interest is only recorded and compiled in a spreadsheet file only when the 
user initiates signal analysis. This is to allow the user to make any necessary sensor 
adjustments to obtain a proper signal prior to analysis and recording of the signal.  
 
 
Figure 6.26: Raw signal down-sampling and storage 
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Data is saved in 4 columns in a text file with column-data designation as 
follows: 
 Column 2: ECG signal 
Column 3: PPG signal 
Column 4: ECG NN intervals signal 
Column 5: PPG NN interval signal 
 
 
Files are by default saved to the desktop in a text file and can be copied to MS 
Excel and plotted (see Figure 6.27). Values for columns 4 and 5 are by default 
given a zero value when no time interval is present. This is due to the method 
of saving the data, where a value for each point is required. As no values are 
propagated into the file when time intervals are not determined, null values 
are then represented as zero. 
 
 
ECG Waveform 
PPG Waveform 
ECG Time Intervals 
PPG Time Intervals 
 
Figure 6.27: Sample recorded data 
 
6.4 Final Design  
The final design of the project utilized both a hardware sensor suite and software analysis 
to detect and display the physiological signals, determine the heart and PRs, and 
respective HRV indices.  
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6.4.1 ECG Electrodes 
Experimental dry electrodes were implemented for the project. The electrodes used for 
the final design can be seen in Figure 6.28. These electrodes were connected into the 
hardware portion of the project through three ECG leads, utilizing standard electrode 
snap connections. Connections for the ECG electrodes were integrated into a single 
connection, which can be seen in Figure 6.29.  
 
 
Figure 6.28: Final ECG electrode 
 
 
Figure 6.29: ECG electrode leads 
 
6.4.2 PPG Sensor Probe 
The MQP group designed a custom sensor probe, roughly modeled after the commercial 
reflectance Oximax MAX-FAST® sensor by Nellcor (see Appendix G). The LED and 
photodiode were mounted on an elastic band with adjustable straps. The MQP group used 
an elastic band due to better stability and previous studies indicated better signal accuracy 
when compared to adhesive tape [53]. The MQP group attached Velcro and elastic bands 
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of various lengths to account for variations in head circumference. The MQP group 
selected a dark headband color to limit optical interference. The photodetection was 
mounted unto the band, and covered with a plastic shield, surrounded by a cushioned 
cloth tape. The MQP group soldered diode wire connections unto a DB9 cable recycled 
from a commercial NONIN finger PPG sensor. The final design is seen in Figure 6.30. 
 
 
Figure 6.30: Reflectance forehead sensor probe 
 
 
 
Figure 6.31: Sensor photodetection unit 
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Figure 6.32: PPG sensor DB9 input connector 
 
6.4.3 Device Hardware 
The MQP group designed the hardware printed circuit board (PCB) using PCB123® 
software from Sunstone Circuits and ordered the PCBs from www.pcb123.com. This 
consisted of a 2 x 3 inch PCB board, with silk screen and corresponding components 
labeled to facilitate soldering. The MQP group soldered the respective components onto 
the PCB (see Figure 6.33). The final circuit drawing can be seen in Appendix B.  
 
 
Figure 6.33: Hardware printed circuit board 
 
Instead of designing and manufacturing a device hardware box, the MQP group 
purchased a readymade box, for better surface finishing. Dimensions of 4.31 x 3.06 x 
1.37 inches were used to accommodate the size of the two 9V batteries. The MQP group 
selected a hardware case with round edges to avoid possibility of sharp edges. MQP 
group mounted and assembled the PCB and device battery inside the device case. Figure 
6.34 shows an isometric view of the device hardware, with labeled device outputs and 
Pin 3: LED cathode 
Pin 4: LED anode 
Pin 1: Photodiode cathode 
Pin 6: Photodiode anode 
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switch. A switch was incorporated into the device box for turning the hardware ON and 
OFF. 
 
 
Figure 6.34: Final device hardware case 
 
 
The MQP group localized device inputs and outputs at opposite sides to avoid confusion 
during connection. DB9 and 3-pin inputs were screwed unto one side of the case for the 
PPG sensor and ECG-lead systems (Figure 6.35). The MQP group used BNC cables as 
device output connectors, in order to be compatible with NI DAQ from National 
instruments (Figure 6.36). The MQP group labeled respective signal BNC connections to 
also avoid further confusion between signals as their labels corresponded to their 
software location processing. The MQP group inserted rubber feet on the device 
hardware floor for proper contact when placing on a surface, due to the probability of the 
device slipping when placed on smooth surfaces. The complete device assembly can be 
seen in Figure 6.37. 
 
Isometric 
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Figure 6.35: Device hardware inputs 
 
 
Figure 6.36: Device hardware output connections 
 
 
 
 
 
Figure 6.37: Final hardware device assembly 
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PPG BNC output 
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6.4.4 Software 
 
Figure 6.38: Final block diagram 
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6.4.5 User Interface 
The device front panel consists of the following features: 
 
 An arrow key button to start signal acquisition 
 A Start button, to begin signal analysis 
 ECG and PPG signal displays 
 Numeric displays for HR, PR, SDNN and rMSSD for respective signals. These 
displays don‟t display any values till the Start button is activated 
 Controls for HR/PR buffer size of IHR/IPR, 5-beat and 8-beat averages 
 Controls for HRV/PRV buffer size of 30s, 1minute and 5minutes 
 Indicators to alert user when SDNN and rMSSD buffers are full 
  A Stop button to stop signal acquisition 
 A visual alarm indicator and High and Low alarm controls.  
 A reset button adjusting the threshold. The automatic reset takes 15s to effectuate. 
However, the threshold can be reset manually 
 Trend Indicator for HR and PR  
 
The complete front panel can be seen in Figure 6.39, and the labeling code is as indicated  
below: 
 
A Start Data Acquisition L PR display 
B ECG Signal display M PPG SDNN display 
C PPG Signal display N PPG rMSSD display 
D Stop button O PRV Buffer Indicator 
E High alarm control P Recording Time Elapsed 
F Low alarm control Q Manual Threshold Reset and LED indicator 
G Alarm LED R Start Data Analysis and LED indicator 
H HR display S Beep Mute Switch and indicator 
I ECG SDNN display T HR/PR averaging control 
J ECG rMSSD display U HRV/PRV Buffer Size control 
K HRV Buffer Indicator V Alarm setting control 
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Figure 6.39: Front panel with labels 
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7. Results 
The results for the project focused on three main parts; the PPG hardware, ECG 
hardware, and the software testing. Each of these three components of the project was 
tested individually to ensure functionality. After it has been confirmed that the hardware 
components of the project were functioning as expected, signals were then put through 
the software component of the project. For this portion, tests and experiments worked to 
confirm that the software was capable of accurately obtaining and analyzing the input 
signals. Errors present in the software portion of the project were also quantified to 
determine their cause and possible methods for attenuating the errors present.   
 
7.1 PPG 
7.1.1 Sensor Probe 
The MQP group designed a wearable forehead sensor for the PPG suite. To compare the 
quality of the sensor, signals obtained from the prototype and a commercial PPG sensor 
were compared. Given the popularity of finger sensors, a Nellcor finger PPG sensor was 
chosen for comparison. PPG signals obtained at 40mA LED drive current from the 
prototype and Nellcor were recorded simultaneously and compared. The 40mA was used 
as reference because typical PR monitors operate around current values of 40 mA or even 
higher e.g. Propaq® 100-50mA, Ohmeda ® -120mA [14]. Typical signals obtained from 
both probes are shown in Figure 7.1. 
 
2V 100mV
 
Figure 7.1: PPG signals from prototype and commercial sensors 
 
Prototype Commercial 
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The MQP group measured on average that signals obtained from the forehead sensor had 
18 times higher amplitudes that that from the finger. Signals from the forehead had 
considerable improvements in SNR compared with the finger. This demonstrated that 
although the finger sensor is popularly used in monitoring systems, other sensor locations 
like the forehead provide better signal quality for data acquisition under motion 
conditions. With a peak-to-peak value of 6V at 40 mA current, this allowed for the 
reduction in current as it was only required that we have at least a 1V peak-to-peak signal 
displayed in the final device front panel. This allowed the possibility of reducing LED 
drive current, to optimize battery life.  
 
7.1.2 Power Optimization 
7.1.2.1 Current Amplitude 
The measurement of high peak amplitudes in the forehead PPG sensor at 40mA allowed 
reduction in LED drive current. The MQP group also kept in consideration that the 
further current reduction decreases signal amplitude, which can affect system accuracy.  
LED currents were varied from 5, 8, 28, 38 and 48mA and their resulting amplitudes 
measured. This exercise was then repeated twice, and subsequent values recorded. Taking 
into account that signal amplitude is subject to variation during different applications, 
relative amplitudes were plotted against current. The relative amplitude was determined 
by taking the ratio of the signal amplitude to the highest measured amplitude of that trial. 
Figure 7.2 shows average values recorded, with standard deviations.  
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Figure 7.2: Plot of relative signal amplitude against current (mA) 
 
7.1.2.2 Current Duty cycle 
The MQP group determined that power can further be optimized by using a pulsatile 
current source to drive the LED. Using a pulsatile power source periodically switches the 
LED on and off, so the total effective time when the diode is off is reduced. A pulsatile 
current reduces the effective current of the LED, with a root mean square value of 
0.01*δ*current, where δ is the current duty cycle. The MQP group evaluated the effect of 
LED current duty cycle on signal quality, to further reduce the power requirement of the 
LED driver circuit. Signals were measured at 20, 40, 60, and 80% duty cycle. Signals 
obtained from various test points of the circuit can be seen in Figure F.1. Figure 7.3 
shows duty cycles measured at the 20 and 80% duty cycles. The MQP group observed no 
observable differences in signal quality measured at the respective duty cycle. As 
expected, signal magnification revealed the existence of small amplitude noise levels, 
which could easily be removed by software filtering. A duty cycle of 20% was selected, 
with approximately calculated values of RA and RB as 150 and 560kΩ for the device 
LM555 timer circuit.  
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Figure 7.3: Detected signals from different LED current duty cycles 
 
7.2 ECG 
ECG hardware tests were conducted to analyze the performance of the hardware sensing 
circuit. The initial circuit design tested is shown in the schematic in Appendix B, Figure 
B.1. The primary goal of the initial circuit was to obtain the ECG with a minimal amount 
of filtering. The circuit shown in Figure B.1 gives the diagram for an instrumentation 
amplifier and HPF to prevent baseline drift. Following the HPF stage, no further filtering 
is done to the signal. The signal obtained, shown in Figure 7.4, contained significant 
60Hz noise. Results for the second circuit design implemented, shown in Figure B.2, are 
similar to those shown in Figure 7.4. For this circuit design, a LPF was implemented, 
however this did not account for 60Hz noise present within the system.  
 
 
Figure 7.4: Initial ECG hardware implementation tests 
 
20 % 80 % 
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After having confirmed the ability to collect the ECG signals, it was then attempted to 
filter the results via hardware based filters. Figure 7.5 shows a signal obtained after 
additional hardware filtering using a 60 Hz band-stop filter to remove signal noise (see 
circuit schematic in Appendix B, Figure B.3). The filter implemented followed the HPF 
and LPF. The band-stop filter worked by using a LPF and a HPF simultaneously with the 
frequency cutoffs set as the band-stop bandwidth. Following this, the signal was added 
together to reform the signal.   
 
 
Figure 7.5: Full ECG hardware filtration results 
 
7.2.1 Electrodes 
Signals quality obtained from different ECG electrodes were assessed and compared. 
Figure 7.6 shows typical signals obtained from gel-electrodes, commercial dry electrodes 
and dry prototype electrode leads. Signals obtained from dry prototype and gel-electrodes 
were comparable. However, signals from the commercial dry electrode belt contained a 
significant amount of noise.  
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ECG Industry Electrodes Test
Lead I Electrodes Gel Lead I Electrodes Dry Exper. Lead I Electrodes Dry Industry
 
Figure 7.6: ECG electrode test results of industry, gel, and dry electrodes 
 
From the results above, the dry electrodes were capable of providing the greatest signal 
amplitude. Of the gel and dry experimental electrodes, signal amplitudes for the gel-
based electrodes were slightly higher. Baseline noise can be seen within each of the three 
electrode options used. Baseline noise is most significant within the commercially 
available dry electrodes.  Baseline noise of the gel-based and experimental dry electrodes 
does not show a significant difference.  
 
7.3 Software Evaluation and Testing 
To investigate the effectiveness of our algorithms, we utilized testing protocols similar to 
that used by Bolanos et al and Johnston et al to compare HRV data obtained from the 
PPG and ECG signals [25], [27]. Both signals produce peaks due to ventricular 
depolarization and this forms the basis for comparison of ECG and PPG derived 
variability indices. The MQP group designed a dual channel monitor to facilitate 
simultaneous recording of both signals. We needed to demonstrate that our software was 
reliable in obtaining raw R-R intervals for HRV calculations as well as show that similar 
HRV data could be derived from ECG and PPG signals.  
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The designed ECG electrodes and PPG sensor were used to acquire signals 
simultaneously from three subjects. Signals were acquired from standard Lead II ECG 
configuration and forehead region, and processed in real time using LabVIEW. The 
experimental set up can be seen in Figure 7.7. All experiments were replicated twice in 
each individual. 
 
 
Figure 7.7: Experimental setup for data recording 
 
Test 1: Basal HR/PR 
Signals were recorded for 30seconds- 2 minutes, with subject at rest to obtain baseline 
HR and PR pulse rates. 
 
Test 3: Motion artifacts 
Subjects were asked to do a series of seven 15 second exercises, in the following order: 
 No motion 
 Upper extremity movement 
 Lower extremity movement 
 Lateral head movement 
 Up-down head movement 
 Fast Breathing 
 Slow Breathing 
 
Forehead  sensor 
  
Lead II electrodes on torso Hardware  
Suite 
Data Acquisition  
board 
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Test 3: Valsalva  maneuvers 
After obtaining baseline rates for 60s, subjects were asked to perform a Valsalva 
maneuvers i.e. forcibly exhaling against a closed mouth and nose. 
 
The standard deviation, standard error of estimate (SEE) and correlation coefficient (R), 
were used for statistical analysis. 
 
 
N
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SEE
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Where Y is the expected value, Yest is the estimated value, and N is the total number of 
points used for the analysis. 
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Where, x and y represents the values being compared and m is the total number of points 
used for the analysis.  
 
7.3.1 Signal Acquisition 
Figure 7.8 (a) and (b) show portions from typical ECG and PPG signals recorded during 
rest. On average, the ECG and PPG signal amplitudes were observed to be above the 1V 
peak-to-peak range, and signal quality was reproducible within all individuals. Both PPG 
and ECG signals exhibited changing amplitudes during rest due to breathing baseline 
drift, although this didn‟t contribute as a nuisance factor. The gradual change allowed for 
proper adaptive threshold peak detection. However, the MQP group observed the 
difficulty in sometimes obtaining the PPG signal as the headband had to be adjusted a 
couple of times for good surface contact. This resulted in tightening of the headband 
straps, which was uncomfortable for the subject. Sometimes this led to a reduction in 
signal amplitude, due to the compression of the artery.   
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Figure 7.8: Typical ECG and PPG during rest 
 
7.3.2 Peak Detection 
The MQP group developed an adjustable threshold peak detection method to account for 
interbeat amplitude variations as well as differences in signal amplitudes between 
individuals. Figure 7.9 (a) and (b) shows the performance of our peak detection 
algorithms, with interbeat interval time calculated shortly after peak observance.  
 
 
(a) 
(b) 
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Figure 7.9: Signal peak detection for ECG (a) and PPG signals (b)  
 
 
The MQP group determined the effectiveness of the adjustable threshold by using 
waveforms of known amplitudes from 0.5 to 2V. Triangular and sine waves from a power 
supply were used to simulate ECG and PPG signals, respectively. The MQP group set a 
threshold at a calibration scalar of 0.75 of the maximum amplitude and increased signal 
amplitude by slow increments of 0.5V, to observe changes in the threshold. The 
measured signal amplitude and calibrated threshold obtained by the peak detector were 
recorded. Table 7.1 summarizes sample results, which shows that the peak detection 
method properly detected maximum signal amplitude and implemented a scalar of 0.75. 
Similar results were also observed using pulse and ramp waveforms.  
 
 
(a) 
(b) 
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Table 7.1: Measurements for Calibrated Threshold 
Wave amplitude 
Measured amplitude 
by peak detector 
Calibrated 
Threshold Factor 
2 1.99 1.498 0.753 
1.5 1.49 1.12 0.751 
1 0.98 0.748 0.757 
0.5 0.498 0.374 0.785 
 
7.3.3 ECG and PPG Data Comparison 
ECG and PPG signals were recorded simultaneously for 2 minutes from subjects during 
rest, and their respective rates compared. Figure 7.10 shows sample results during one 
recording session using our initially developed algorithm.  
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Figure 7.10: Simultaneously recorded HR and PR   
 
The MQP project group observed that the PR deviated significantly from HR with a 
negative bias. The MQP group used statistical analysis to determine that the PR 
underestimated HR with a standard deviation of ± 13bpm. It was determined that the 
main reason for this difference was the difficulty in determining peaks in the PPG 
waveform due to its rounded peak shape, as opposed to a sharp peak like that of the R 
wave in ECG waveform. There is also the presence of a dicrotic notch that can introduce 
false peaks. The MQP implemented a derivative method to obtain a waveform with a 
more distinct peak, and better separated the signal amplitude due to the dicrotic notch 
(see Figure 7.11).  
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Figure 7.11: PPG signal (a) and corresponding derivative (b) 
 
In addition to these deviations, the MQP group observed missed beats (about 2 for every 
100 beats), highlighed as sharp drops in respective rates (see Figure 7.10), and this falsely 
activated the system alarm. The MQP group stipulated that the missed beats occurred due 
to the inability of the threshold detection window to adjust itself, especially if a peak was 
located just at its boderline. A default system value of around 8 bpm was thus output, 
hence the observance of the sharp drops. Due to time limitations, the MQP group could 
not implement an adjustable threshold detection window, and so developed an algorithm 
to ommit these missed beats. Initially, when this was implemented it resulted in double 
values because time interval of the beat prior to a  missed one was duplicated. 
  
Figure 7.12 shows a plot of measured interbeat interval against time. The two abnormally 
high beats represent this phenomenom of time interval doubling. The MQP group 
implemented an algortihm to reject this abnormally high intervals, by comparing 
interbeat interval values with each other, and rejecting those that time intervals beyond 
175% of their respective previous interval. Figure 7.13 shows the occurrence of a missed 
beat, but with no interval double count. 
 
 
(a) (b) 
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Figure 7.12: Beat-to-beat interval double count due to missed beat 
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Figure 7.13: Beat-to-beat double count rejection 
 
After optimizing our software we obtained a significant improvement in correlation 
between HR and PR. As observed in Figure 7.14, PR consistently followed HR, and we 
calculated that PR deviated from HR with a standard deviation of ± 1.5bpm. Using  MS 
Excel, we plotted a scatterplot of IHR and IPR to calculate correlation coefficient, R. 
Figure 7.15 shows a linear relationship between these two calculated rates with 
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89.07866.0 R , a similar value to that obtained by Johnston et al (R=0.9) with their 
algorithms to compare HRV data derived from PPG and ECG signals [27]. 
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Figure 7.14: Corrected HR and PR from resting subject 
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Figure 7.15: Comparison of between instantaneous HR and PR  
 
SDNN and rMSSD indices obtained from simultaneous 2 minute recordings of both 
signals were compared. Comparison of inter-beat variability from data sets showed a 
close linear correlation between ECG and PPG indices, with a correlation coefficient of 
0.88 and 0.94 for SDNN and rMSSD indices respectively. 
 111 
 
y = 0.8827x + 3.0626
R2 = 0.7722
n=8
10
20
30
40
50
60
70
10 20 30 40 50 60 70
ECG SDNN (ms)
P
P
G
 S
D
N
N
 (
m
s
)
 
y = 0.8827x + 3.0626
R2 = 0.7722
n=8
8
18
28
38
48
58
68
8 18 28 38 48 58 68
ECG rMSSD (ms)
P
P
G
 r
M
S
S
D
 (
m
s
)
 
Figure 7.16: Comparison of SDNN (a) and rMSSD (b) variability indices 
 
7.3.4 Motion Artifact 
The MQP group was able to demonstrate good correlation between HRV measures 
obtained during rest. However, in order to determine if the developed algorithms could be 
efficient under motion, subjects were made to undergo a series seven continuous 15 
second exercises, of moderate and high intensity. These exercises are summarized in 
Table 7.2.  
 
(a) 
(b) 
 112 
Table 7.2: Time duration for motion activities 
Order Activity Time(ms) 
1 No motion 1-1500 
2 Upper extremity movement 1501-3000 
3 Lower extremity movement 3001-4500 
4 Lateral head movement 4501-6000 
5 Up down head movement 6001-7500 
6 Fast breathing 7501-9001 
7 Slow breathing 9001-10500 
 
Figure 7.17 shows typical signal HR and PRs recorded from a subject under sequence of 
moderate (a) and high intensity (b) movement exercises. The MQP group determined the 
average HR and PR as well as standard deviations during these activities. Figure 7.18 (a-
b) and Figure 7.19(a-b) summarizes the degree of variation during the motion exercises.  
The error bars represent the standard deviation or degree of rate variation during each 
exercise. 
 
Similar rates and standard deviations were observed during moderate motion exercises. 
Overall, ECG signals demonstrated better signal stability during motion exercises, even 
though signals were more or less affected by limb movements. Increased signal noise was 
observed for the ECG, especially during upper body motion, due to additional noise 
introduced by the EMG signal. The PPG signals were most susceptible to increased 
distortion during head movements as well as high intensity exercises, leading to a greater 
degree of variance. This demonstrates the ever occurring challenge there is in designing 
wearable PPG sensors. While good signal correlation was observed during rest, better 
processing algorithms to eliminate motion artifacts need to be implemented to allow for 
long term patient monitoring of HRV using the PPG signals.  
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Figure 7.17: Comparison of HR and PR values during low (a) and high (b) activity 
 
Table 7.3: Activity level statistical data 
Activity Low Intensity High Intensity 
 ECG PPG ECG PPG 
Upper Body Motion 84± 4 83± 5 95± 7  94± 8 
Upper Body Motion 88± 8 89± 8 101± 18 91± 2 
Lower Body Motion 93± 7 92± 3 100± 9 100± 11 
Lateral Head Motion 95± 6 93± 7 92± 5 91± 15 
Up-Down Head Motion 90± 5 91± 8 89± 4 86± 13 
Fast Breathing 85± 8 87± 7 94± 4 96± 12 
Slow Breathing 90± 5 89± 7 101± 9 102± 14 
 
 
(a) 
(b) 
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Figure 7.18: Comparison of HR (a) and PR (b) during moderate intensity movement 
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Figure 7.19: Comparison of HR (a) and PR (b) during moderate intensity movement 
 
 
7.3.5 Comparative Software Validation 
7.3.5.1 ECG 
The ECG signal algorithms were validated against a simulated ECG signal of known 
frequency values at rates of 30, 60 and 120 beats per minute. This signal contained all of 
the major signal components for an ECG signal, including the P wave, QRS complex, 
and T wave. The expected time intervals were compared to averages interbeat time 
intervals obtained from the system. Each of the three signals was applied to the system 
over a period of time. Time periods from the start and end of the signal acquisition were 
(b) 
(a) ECG 
PPG 
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omitted to ensure that the simulated signal entering the system was at equilibrium, 
attenuating possible errors within the simulated signal itself.  
 
Table 7.4: ECG Validation Results 
Beats per 
Minute 
Number of 
Peaks 
Averaged Time 
Between Peaks 
Expected Time 
Between Peaks 
Percent Error 
30 9 2.0036 2.00 -0.18 % 
60 9 1.0044 1.00 -0.44 % 
120 19 0.5073 0.50 -1.46 % 
 
The results shown in Table 7.4 give the error percentages for each of the three HRs, with 
a percent error of less than 2 %. On average the system is accurate within ±0.1 beats per 
minute for rates up to 120, and ±3.0 beats per minute for rates greater than 120.  
 
7.3.5.2 PPG 
The MQP group used Masimo SET monitor as a one standard to verify the reliability of 
our software algorithm for the PPG signal. The MQP group obtained PR simultaneously 
from our prototype and the commercial monitor. Figure 7.20 (a) shows a typical 2 minute 
recordings. Initially, we determined that PR values obtained from the prototype deviated 
significantly from that of the gold standard with a standard error of estimate (SEE) ± 
5bpm.  
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Figure 7.20: PR comparison between prototype and commercial PPG devices 
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The MQP group was unable to obtain the algorithms used to compute that PR in the 
commercial sensor due to trade secrets. Most monitoring device use different algorithms 
to compute PR and this might be a possible reason for the observed difference. However, 
because we observed an improvement in device accuracy after optimizing our software, 
this demonstrated that we solved some of the problems created by the difficulty of 
processing the PPG signal by using the derivative method of peak detection. 
 
7.3.6 Manual Software Validation 
The MQP group was able to validate device software against an ECG simulator and a 
commercial PPG device. However, for proper validation, it was determined that 
comparison between manual calculations and our software calculations of PR and HR, 
would better demonstrate the effectiveness of our algorithms. This was due to the 
uncertainty in guaranteeing the exact signal frequency in the ECG simulator, as well as 
unknown algorithms for the Masimo SET monitor. ECG signals were recorded for about 
30s during rest. R-R intervals obtained from our software as well as those that were 
manually calculated were compared. This analysis revealed that those obtained from our 
software didn‟t exhibit a normal physiological pattern (see Figure 7.21). 
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Figure 7.21: R-R Interval comparison between manual and software calculations revealing 
inaccuracies in software algorithm 
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During rest, the ECG of healthy individuals exhibits rhythmic variation in R-R intervals, 
a phenomenon known as respiratory sinus arrhythmia (RSA). RSA fluctuates at the phase 
of respiration; cardio-acceleration during inspiration, and cardio-deceleration during 
expiration [4]. This is observed in the manual R-R interval plot above, where the R-R 
intervals gradually rise and fall and R-R intervals do not typically differ over 20% from 
adjacent values during rest. However, the pattern observed from R-R intervals 
determined by our software did not exhibit this RSA, with a more or less jerky R-R 
interval pattern.  
 
The MQP group determined that this was due to resolution errors in the timer method we 
implemented to calculate R-R time interval  This time interval detection method was later 
replaced with a method that used the number of data points between peaks to calculate R-
R interval. A significant improvement was obtained with this new algorithm as almost 
exact correlation was observed between R-R intervals that were manually calculated as 
well as that obtained from our software (see Figure 7.22 ). An SEE of 0.13bpm or ≈ 
0bpm of inter-beat interval was obtained using this method. 
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Figure 7.22: R-R Interval comparison between manual and updated software calculations for ECG  
 
 
Results from SDNN and rMSSD indices obtained from ECG signals recorded for about 
30s from three individuals are summarized in Table 7.5. These results demonstrate a 
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good correlation between SDNN and rMSSD indices of our software with respect to 
manual calculations. The average percentage errors obtained from these recordings were 
0.45±0.27% for SDNN and 0.77±0.80% for rMSSD (ms units). 
 
Table 7.5: HRV Measures from 3 subjects 
Suresh 
 Software Manual % error 
Average HR (bpm) 67 67  
SDNN (bpm) 2.6 2.6 0 
rMSSD (bpm) 3.1 3.1 0 
SDNN (ms) 34.8 34.7 0.28 
rMMSD (ms) 40.8 40.7 0.24 
Thomas 
 Software Manual % error 
Average HR (bpm) 94 94  
SDNN (bpm) 3.9 3.9 0 
rMSSD (bpm) 2.5 2.6 3.84 
SDNN (ms) 26.1 26.3 0.76 
rMMSD (ms) 17.4 17.7 1.69 
Boyla 
 Software Manual % error 
Average HR (bpm) 77 77  
SDNN   (bpm) 6.2 6.2 0 
rMSSD (bpm) 7 7 0 
SDNN   (ms) 65.2 65 0.31 
rMSSD (ms) 78 77.7 0.38 
 
Using the new algorithms, IHR and IPR from simultaneously recorded signals were re-
evaluated and compared. Figure 7.23 shows IHR/IPR from software and manual 
calculations, against their respective beats, with an even better correlation between ECG 
and PPG derived instantaneous rates. Using  MS Excel, we plotted a scatterplot of IHR 
and IPR with the new algorithm and obtained an R of = 9841.0 = 0.99, an 11.2% 
increase from the previously calculated coefficients of 0.89. Based on this improvement, 
we infered a likely improvement in SDNN and rMSSD correlation between ECG and 
PPG signals.   
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Red: Manual calculation of IHR (bpm) 
Green: Software calculation of IHR (bpm) 
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Red: Manual calculation of IPR (bpm) 
Blue: Software calculation of IPR (bpm) 
 
Figure 7.23:  Manual and Software IHR (top) and IPR (bottom) Correlation 
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Figure 7.24 Comparison of between IHR and IPR with updated software 
 
 
7.3.7 Valsalva Maneuvers 
To better test the capacity of our device to measure dynamic HRV, as opposed to steady 
state conditions such as during rest, subjects were asked to perform a Valsalva maneuver. 
The Valsalva maneuver is a common test of sympathetic nervous system function which 
involves forcibly exhaling against a closed mouth and nose. This causes a temporary 
decrease in blood output from the heart, and people with fully functioning sympathetic 
system compensate for this decrease by increasing HR [55]. This exercise produces a 
characteristic feature with an up rise-and-decline in HR or a decrease-and-increase in R-R 
intervals, upon release. After obtaining a baseline HR for 1 minute, subjects were asked 
to perform a Valsalva maneuver and release at their convenience. Figure 7.25 (a) and (b) 
shows comparison between manual and software calculations of IHR and R-R intervals 
during one Valsalva maneuver. From the figures, our software was able to pick up the 
changes in HR during the Valsalva exercise, demonstrating its effectiveness in being able 
to detect other forms of physiological HRV.  
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Figure 7.25: IHR (a) and R-R Intervals (b) changes during a Valsalva maneuver 
 
7.4 FDA Regulations 
Prior to marketing any medical device, manufacturers have to fulfill specific standards 
and regulations of the US Food and Drug Administration (FDA), under the Federal Food 
Drug & Cosmetic (FD&C) Act. Title 21 Code of Federal Regulations (CFR). This 
includes protocol for proper testing of the device prior to FDA approval as well as 
labeling, marketing, and post-market monitoring procedures. Other regulatory 
requirements also follow depending on the device class, which evaluates the risk of using 
the device. Devices are classified Class I for (low risk, general controls), Class II (special 
(a) 
(b) 
Valsalva maneuver 
Valsalva maneuver 
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controls) and Class III (high risk, premarket approval) depending on the risk of the device 
user.  
 
Based on an FDA database search of HRV monitors, our device would be likely be 
classified as a Class II device. For FDA approval, this would require a submission of a 
510(k), with clinical data to demonstrate that our device is comparable to others already 
available in the market, in terms of safety and effectiveness. Our various tests were 
performed on a small group of individuals, with presumably normal heart conditions. 
Hence, further device testing needs to be carried out on a more significant population, 
especially that representative of those who are going to using the device i.e. cardiac 
patients. Also, although our device hardware is battery operated and contained within an 
insulated container, we could not demonstrate if the device was waterproof to assess the 
risk of electric shock as this would involve destructive testing. The device was labeled 
not to be used around any fluids. 
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8. Analysis and Discussion 
8.1 PPG 
One of the challenges in designing wearable biomedical sensors is guaranteeing signal 
integrity during acquisition. Placement location of sensors plays an important role as it 
can affect signal quality. For the PPG, while signals obtained from forehead and finger 
sensors are obtained via different detection modes, the considerable increase in signal 
amplitude with the forehead sensor demonstrates its superior characteristics (see Figure 
7.1). Signals obtained via reflectance mode from the forehead are generally strong due to 
the combination of thin skin tissue layer as well as high bone density that facilitate light 
reflection. The high signal amplitude allowed for significant reduction in LED drive 
current to improve on device battery life. In addition, it is also important to design a 
proper sensor package to guarantee good surface contact, especially for long tern 
recordings. While signals obtained from adhesive and headband sensor probes were 
similar, the adhesive probe was more susceptible to dislocation as a result of wear of the 
glue adhesive. A headband forehead sensor is thus preferred due to its greater stability. 
 
Optimizing power consumption is also important due to the major power requirement of 
the PPG device LED, as it is directly related to the amount of LED drive current. 
Although drive current can be reduced, this has a diminishing effect on signal amplitude, 
due to the effective reduction of light intensity detected by the photodiode (see Figure 
7.2). Low signal amplitudes can adversely affect accuracy during signal processing. Thus 
there has to be a balance between reducing current and obtaining a signal of adequate 
amplitude for signal analysis. From Figure 7.2, the positive linear relationship confirms 
that current values indeed have an effect on signal amplitude. Current values below 5mA 
resulted in signals with high SNR. The MQP group determined that a current of about 
8mA achieved the right compromise between minimizing current and attaining adequate 
signal quality.  It is also important to note that this value is specific for our selected LED 
and photodiode characteristics, and might change when different supplier LED‟s are 
used. Savage et al were able to observe adequate PPG signals with as low current as 
1.9mA in multi photodiode forehead reflectance sensor [23]. The MQP group 
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hypothesizes that if the photodetection area of the photodiode is increased, this current 
requirement can further be reduced. 
 
Alternatively, LED drive current can be reduced by reducing the duty cycle of the LED 
drive current i.e. the time between which the LED is turned on and off during signal 
acquisition. Nyquist sampling theorem dictates that a sampled signal can be reconstructed 
to its original waveform as long as the sampling frequency is at least twice the maximum 
frequency content of the signal. For the PPG waveform, a sampling rate of at least 20 Hz 
can satisfy this requirement. Switching the LED on and off thus “samples” the PPG 
signal at a rate equal to the duty cycle of the current. The signal is “reconstructed” with 
the sample hold circuit. A pulsatile current reduces the effective current of the LED, with 
a root mean square value of 0.01*δ*current, where δ is the current duty cycle. Battery life 
of the device is thus inversely proportional to the LED drive current. Estimated battery 
life calculated from a typical battery of 500mAh for various current modes is compared 
in Table 8.1.  
 
Table 8.1: Comparison of estimated battery life for different LED currents 
Current Duty Cycle Battery Life Estimate 
40mA DC 12.5 hours 
8mA DC 62.5 hours 
8mA 20% 312.5 hours 
 
However, this does not take into account the power requirement of the other device 
components. Nonetheless, since the PPG circuit consumes a significant amount of power 
in the device, it can be assumed that battery life estimated from its power requirement can 
give a fair estimate as to the expected battery life. The battery life estimate improved by a 
factor of 25, using a lower current and reduced duty cycle current source. 
 
8.2 ECG 
Tests for the ECG section of this project involved determining the functionality of the 
circuits, and their abilities to acquire a clean signal from the given sources. Original tests 
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with the ECG section focused on acquiring the signal through the hardware based 
sensors. As discussed in Section 5.2.3, the two possible design alternatives were to 
completely filter the ECG signal through hardware, or for limited hardware filtering only 
as necessary with software filtering. Tests were accomplished using both circuit design 
types. The original results obtained were through using the limited hardware filtering. 
This design was to limit the number of hardware components to the minimum necessary 
to acquire the signal. As this portion is necessary for all other designs of the circuit, it is 
the basis for both the expanded and limited versions of the hardware. The limited circuit 
design can be seen in Figure B.1 as Revision A. This circuit design consisted simply of 
an instrumentation amplifier to acquire the signal and a single high-pass filter to remove 
baseline drift from the signal. Results obtained using this design can be seen in Figure 
7.4. With this design, it is important to note that there is significant high frequency noise 
within the system. Without further filtering this may prevent the location and analysis of 
the smaller features of the ECG signal. From the signal, the P and T waves can both be 
identified due to the displacement of the baseline noise. This however is not an effective 
method for analysis, since specific features of the waves are not readily visible. An 
additional problem may arise should the baseline noise and QRS peaks not be sufficiently 
different. Should this become true, it may not be possible to locate the peaks of the signal 
in order to perform signal analysis for determination of the HR and variability indices. 
 
To account for the problems seen with Revision A, shown in Appendix B, a second ECG 
hardware design was developed to improve the acquired signal. This design was to 
include signal acquisition and complete filtering utilizing analog hardware filters. Initial 
tests for this were conducted using the second circuit design revision, shown in Figure 
8.1. This circuit design implemented both a HPF and LPF. Use of this design was to 
attenuate any problems associated with baseline drift with the HPF and eliminate high 
frequency noise through the LPF. Results however did not show a significant difference 
from the previous tests conducted with Revision A (Refer to Figure 7.4 for example 
results).  
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Figure 8.1: ECG circuit Revision B 
 
The final circuit revision was to attenuate noise due to 60 Hz corruption. This was 
accomplished by utilizing a HPF to eliminate possible baseline drift of the signal, a low-
pass filter to remove high frequency noise, and a band-stop filter to eliminate 60 Hz noise 
from within the signal. The band-stop filter had a stop frequency of 60 Hz and a 
bandwidth of 20 Hz. The schematic for this design alternative can be seen in Figure B.3. 
The results of implementing this design can be seen in Figure 7.5. Using this design, the 
problems within the signal associated with the 60 Hz noise were significantly reduced. As 
can be seen within the figure, there continues to be a minor form of baseline noise. 
However, this noise is significantly reduced from the prior tests, as the noise component 
of the signal is of lower amplitude than the P and T waves. This in itself allowed for a 
greater ability for signal analysis both from the software to determine rates and with 
graphical analysis of the raw waveform by a clinician.  
 
Of the design alternatives, analyzed in Section 5.2.3, the final design choice was to use 
the minimum number of hardware filters. The rational for this is that by reducing 
hardware components, there is a reduced possibility of component failure and lower 
device costs. Additional filtering necessary to analyze the signal can be accomplished 
through digital software filters. The final design choice was to use the Revision A circuit 
design, output results shown previously in Figure 7.4. Using this implementation, the 
signal was primarily processed through software filtering algorithms. By utilizing this 
 128 
method, the overall design of the hardware was simplified by removing unnecessary 
components, thus reducing the possibility for component failure. As an example, final 
results of filtering can be seen in Appendix F, where the overall benefits of the final filter 
design are shown. This overall design, utilizing only minimal filtering within the 
hardware, provided for the majority of the filtering to be done by the software component 
of the project. Filtering within the software allowed for a more precise signal filtering, 
thus allowing for additional signal artifacts to be removed from the signal. As can be seen 
Figure 7.6, the baseline noise of the signal has been further reduced. This implementation 
of the design was better equipped to adhere to the design objects, set forth in Section 4.3. 
Minimal hardware components complimented the reliability objects by reducing the 
possibilities for device failure, thus increasing durability, and reducing the overall device 
costs.  
 
For this project, dry electrodes were developed and tested. The purpose of this was to 
create electrodes for general use that would not be affected by problems such as skin 
irritation and electrode gel drying [11]. The different design alternatives for the 
electrodes that were tested are further described in Section 5.2.1. Following the analysis 
and selection of the design alternatives, the experimental electrode was tested in 
comparison with standard industry electrodes. Three tests were run to compare the results 
obtained using a Lead I setup; (i) using the experimental dry electrodes, (ii) using 
standard gel-based electrodes, and (iii) commercially available dry electrode suite. These 
two final tests were run to determine the effectiveness of the experimental electrodes with 
regards to current industry products. The test results, seen in Figure 7.6, showed the gel-
based electrodes and the experimental dry electrodes to be comparable in signal content. 
Within each signal the P wave, QRS complex, and T waves are clearly visible. Major 
differences between the gel and experimental dry electrodes are that the experimental dry 
electrodes have a slightly lower peak value in comparison. This is due to the higher skin 
resistance between the skin and electrode metal contacts, normally attenuated through the 
electrode gel. Comparison between the experimental dry electrodes and a commercially 
available electrode suite, shown in Figure 8.2, revealed significant differences between 
the two signals amplitudes. The commercial electrode suite, being placed closer to the 
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heart, provided a signal of greater intensity. However, also within the signal there is a 
greater degree of baseline noise when using the commercial electrode suite. This may be 
due to problems associated with physical movement of the electrodes, which can cause 
baseline drift and additional noise within the signal due to capacitive coupling [11]. A 
specific example of this can be seen at approximately the midpoint of the commercially 
available signal test. At this point there is a significant increase in the amount of baseline 
noise due to movement of the electrode suite, due to movement of the patient. This 
problem is eliminated with the use of the experimental dry electrodes as each electrode is 
isolated on the body, with the perimeter of the contact surrounded by vinyl adhesive to 
secure the electrode in place. The experimental signal shown within the test results is the 
most robust of the tested electrodes for abilities to maintain a stable baseline value, and 
reduce the amount of baseline noise within the signal.  
 
 
Figure 8.2: Industry dry electrode suite 
 
Of the electrode tests, the experimental electrodes chosen in Section 5.2.1 provided an 
inexpensive option for attaining the project objectives. The experimental electrodes 
selected do not contain any electrode gel used for conduction. For this reason, there is no 
possibility for the electrode properties to alter over time. Furthermore, there is no gel for 
there to cause skin irritation with the user. Lastly, the user friendly object for the 
electrodes was met by simplifying the placement of the electrodes. Using easy to locate 
areas on the body, users of the device require no specialized training to locate the 
appropriate electrode locations, instructions for which are given in Appendix E.  
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8.3 Software 
HRV data has been used to assess cardiovascular irregularities in patients with SCD. This 
data is traditionally obtained from ECG signal analysis. However, problems associated 
with ECG gel-based electrodes limit the utility of the signal for long term monitoring. 
Alternatively, since changes in blood volume during the heart cycle are reflected in as 
pulsations in arterial blood flow, PPG signals can be used to derive the same 
physiological data for HRV analysis. PPG systems offer the various advantages, as 
discussed in Section 2.4, of more compact sensor packages, fewer sensor wires, no 
electric interference, as well as more user comfort. A correlation coefficient close to 1 is 
thus desired between calculated values obtained from both signals, to demonstrate their 
close relationship. 
 
The MQP group implemented software algorithms to determine and calculate IHR/IPR 
through signal peak detection. The threshold peak detection was made adaptable to 
account of physiological differences in signal amplitudes, as well as variations between 
individuals. The close agreement between manually calculated values and those obtained 
from our software revealed that our algorithms were robust and accurate in determining 
beat-to-beat interval with a lesser degree of error after software optimization. Statistical 
analysis of data from three individuals during rest revealed a SEE of 0.13bpm for IHR 
and an average percent error of 0.45±0.27% for SDNN and 0.77±0.80% for rMSSD 
indices (ms units). The ability of our software algorithms to track dynamic HRV was best 
demonstrated during the Valsalva‟s maneuvers, where the characteristics time series plots 
for R-R or IHR were observed during the exercise.  
 
Correlation coefficient of 0.99 was calculated between IHR and IPR from simultaneously 
recorded ECG and PPG signals during rest. By inference, a more improved correlation of 
their SDNN and rMSSD indices, from the previously calculated values of 0.88 and 0.94. 
This indicates the strong relationship between these two signals, thus PPG signals can be 
used as an alternative to the ECG signal. Johnston et al identified the difference in the 
geometry of PPG signals as a potential reason for not being able to perfectly achieve a 
correlation coefficient of 1 [22]. Unlike the ECG signal, which has a distinct QRS 
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complex, the lack of a distinguishable peak makes it difficult to process PPG signals. By 
using a differential peak detection method, signal correlation was greatly improved. 
However, missed beats was observed due to the lack of routinely adjusting peak detection 
window during signal processing. A better alternative will be to create a variable self 
adjustable window that updates itself based on signal peak-to-peak time interval duration. 
 
Motion artifacts are a considerable limitation in signal processing. The application of this 
device necessitates the stability of signals as well as accuracy of calculated measures 
during continuous patient monitoring. In ECG, muscle activity poses a great problem due 
to the overlapping bandwidths of ECG and EMG signals. In PPG, sensor movement and 
severity of motion artifacts, (usually dependent on sensor location) poses a significant 
problem in system accuracy. There was good signal correlation during moderate motion 
activity, although the ECG waveform demonstrated greater stability during movement 
exercises. As expected, increased signal noise was observed in the ECG especially during 
limb activities. The noise intensity was more severe during upper limb movements, 
significantly masking the P and T waves of the signal. This is due to the relatively close 
positions of active muscles of the upper limbs to the ECG electrode system leads. 
However, it was still possible to obtain good HR values due to the stability of the high 
amplitude QRS complex. Poor signal correlation was obtained from the PPG waveform, 
especially during head movements, causing a greater variance in PR.  
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9. Conclusion 
The dual channel HRV monitor developed has the potential to impact the global society 
by providing a new tool for physicians and scientists. Given the large number of people 
affected by SCD, the data provided can aid their inquiries on noninvasive methods of risk 
stratifying patients susceptible to SCD.  
 
The dual channel HRV monitor is capable of acquiring and processing ECG and PPG 
signals to obtain HR, PR, and their respective variability indices. Manual calculations 
confirmed the robustness and accuracy of our algorithms, with lesser degree of error in 
computing interbeat intervals, SDNN and rMSSD indices. Correlation coefficient 
obtained from the analysis of the system outputs for the IHR and IPR of 0.99, revealed 
that similar data measures could be obtained from both signals. The ability of the device 
to track dynamic changes in HRV was also demonstrated via Valsalva maneuver, where 
the characteristic time series plot of IHR and R-R intervals, during this exercise was 
observed.   
 
By reducing power requirements of the PPG through reducing current amplitude and duty 
cycle, device battery life was optimized by an estimated factor of 25. Dry electrodes were 
shown to function as effectively as gel-based electrodes in providing adequate signal 
amplitude while reducing the effects of skin irritation. The software was shown to 
perform adequately under moderate motion artifacts situations and produced results 
showing good correlations between the HR and PR, as well as their respective variability 
indices. However, further developments for the software analysis and sensor suites 
should focus on allowing the system to perform reliably under situations of greater 
motion artifacts.  
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10. Recommendations 
10.1 PPG  
10.1.1 PPG Circuit 
The MQP group recommends that the total number of components in the PPG circuit be 
reduced, to decrease large scale device costs as well as minimize the possibility of 
component failure. This might include a shift to entirely software filtering, using more 
robust filters. 
10.1.2 Device Battery life 
Battery life can also be improved by increasing the effective photodetection area through 
multiple diode usage or a diode with increased area. This allows for a decrease in the 
overall light output for the light emitting diode, hence lesser current, due to the increase 
probability of diffused light detection. The MQP group recommends a using a PPG 
sensor architecture with the photodiodes arranged concentrically around the LED source. 
Another desirable feature for this device would be a low battery indicator to alert the user 
that a change is required, in order to avoid system failure during monitoring. The MQP 
group utilized two 9V batteries for the device design, with the option of using 
rechargeable type batteries to reduce device cost. However, smaller sized batteries like 
coin cell batteries can be used to further reduce device hardware size, and maintain it 
within a PDA size range. 
10.1.3 Motion Artifact Reduction 
Given the importance of signal integrity in wearable monitoring sensors, it is critical to 
remove noise components especially due to motion artifacts. The MQP group 
implemented a frequency based signal filtering methods to remove high frequency noise. 
However, this method was not effective in completely eliminating motion artifacts, 
resulting in signal distortion and possibility of system accuracy errors during 
measurements. In this design, the MQP group minimized the effect of motion artifacts by 
rejecting abnormally high peak amplitudes or short R-R interval times introduced by 
multiple peaks. Further reduction motion artifacts will provide the system better clinical 
acceptability to ensure accurate measurements.  
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The MQP group recommends adaptive filtering for motion artifacts reduction as it has 
been demonstrated to be a more effective method of noise cancellation in PPG signals. 
This is based on the fact that since noise signal is not removed as a result of bandwidth 
overlap, its frequency content can be “subtracted” from the signal of interest to obtain a 
better signal (see Figure 10.1). A reference signal is usually used to simulate the noise 
component since actual noise signal is usually unknown. The characteristics or tap weight 
of the adaptive filter changes in an effort to minimize the error resulting from this 
subtraction. 
 
Adaptive Filter
+
-
Corrupted PPG signal
Reference noise signal 
From accelerometer
Clean PPG signal
Error
 
Figure 10.1: Adaptive noise cancellation for motion artifacts reduction in PPG signal 
 
A signal from an accelerometer can be used as a reference signal for reduction in motion 
artifacts in PPG signal analysis. An accelerometer generates an electrical signal 
proportional to body acceleration. Relente et al. utilized a Recursive Least Square 
adaptive filter, using signals from a single axis accelerometer as a reference signal [57]. 
They determined that a filter with coefficients λ=0.999 and N=32 was effective in 
reducing motion artifacts with a HR to within a ±5% error.  
 
The MQP group also proposes the exploration of removing motion artifacts by signal 
correlation. Weng et al proposed cross-correlation to minimize motion artifacts in the 
PPG waveform. This is based on the fact that if waveforms from one cycle do not match 
those of previous or an average reference waveform, most likely it is due to artifact.  
Following cross correlation detection, this section is either truncated or extrapolated 
depending on the severity of the motion artifacts. By comparing signal quality before and 
after signal algorithm implementation, they were able to demonstrate that their proposed 
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cross-correlation detection was effective in enhancing signal to noise ratio of the PPG 
waveform. 
 
10.1.4 Sensor Platform 
One limitation of the sensor platform designed by the MQP group is the introduction of 
additional artifacts due to the wire motion. There is also the possibility of wire 
entanglement, which is undesirable in ambulatory conditions. Modern wireless 
communication technology have proved a significant medical innovation, as it has 
allowed for better health care management through rapid communication of data between 
physicians and patients. The MQP group suggests using an integrated cordless sensor and 
microprocessor technology to assimilate sensor components into a single small unit and 
signals obtained wirelessly transmitted to a processing unit. This further reduces the 
burden on the user of carrying the device at all times. In a pilot study, Lindberg et al were 
able to demonstrate the possibility of using the area above the radial artery as a PPG 
sensor location site by using a wireless PPG sensor [58]. Mendelson et al. have developed 
a PDA-based wireless reflectance forehead sensor for monitoring HRV and other 
physiological conditions of soldiers in the battlefield, for better care management of 
especially injured soldiers [21]. 
 
Sometimes it was necessary to adjust the PPG headband sensor a couple of times in order 
to obtain a proper signal. To alleviate this problem, sometimes the band had to be tightly 
fastened for good skin contact. This often led to a reduction in signal amplitude due to 
compression of the blood vessels beneath the skin. This also resulted in sensor 
demarcations on the forehead, suggesting that the device was not properly shielded, with 
the possibility of patient skin inflammation and injury. The MQP groups suggest softer 
and pliable plastic materials for shielding to minimize patient injury.   
 
The materials used for the sensor also have to be improved to make it more durable to 
guarantee sensor integrity during multiple uses. The sensor designed by the MQP group 
utilizes a sports band as an attachment method, which may not be clinically acceptable in 
terms of biocompatibility, as some people can develop skin reactions. Proper textiles, 
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which are clinically acceptable, will have to be used. The aesthetic appearance of the 
sensor can also improved by making it smaller, to improve on patient comfort.  
 
10.2 Device Testing 
Although the MQP group was able to demonstrate the correlation of HR and HRV 
indices in a small group of individuals with assumingly good heart conditions, it is 
necessary to demonstrate the effectiveness of our device and reproducibility of our results 
on heart patients requiring monitoring. Extensive clinical testing on a significant 
population is thus necessary to validate and qualify our device for clinical use especially 
for FDA device approval. Although the device hardware was portable, the additional bulk 
from the PC severely limited the nature of our motion tests. These motions studies are 
indeed vital since it plays a significant limitation of PPG sensor usage. As noted above, 
elimination of the PC will render our device more portable for better motion exercise 
testing or better yet, longer monitoring times.  
 
The MQP group also determined that the rMSSD and SDNN indices were not effective in 
obtaining valid measurements during motion. The MQP suggests the possibility of 
exploring geometrical based frequency domain methods, as recommended for long term 
studies such as the Poincaré plot. This is because abnormal heart beats will usually be 
observed as outliers in the plot.  
10.3 ECG 
The following recommendations are focused on improving the sensor interface of the 
ECG. These improvements are intended to provide for a better interface with regards to 
acquisition of the ECG signals. Utilizing a better acquisition of the signals allows for an 
overall better quality of the signals to be analyzed. Overall, the better quality signals will 
provide for better signal analysis, and more reliable data.  
 
10.3.1 Adaptive Filtering (Active EMG) 
The ECG sensors did not perform well enough to perform exercise while monitoring the 
electrical signals of the heart. This is primarily due to the overlapping of EMG 
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frequencies with ECG frequencies. Tests with this type of noise have shown that it is 
isolated primarily to the upper body movement, which correlated well with the placement 
of the electrodes and the areas of muscle activity. Potential problems with this may arise 
when utilizing the system while performing an exercise. This may be especially true 
when performing a cardio related exercise where the entire body is in motion. Such an 
event would cause widespread EMG artifacts within the ECG sensors, causing a poor 
quality signal.  
 
A possible improvement for this would be through active noise filtering. For this to be 
accomplished, a second set of sensors would need to be placed to obtain the EMG. This 
signal would need to be acquired in such a fashion that only the EMG signals are 
acquired, isolating other possible signal artifacts from possibly entering the system. 
Theoretically, the attempt is to remove the EMG artifact from a signal containing an ECG 
and EMG signal, thus providing a clean ECG signal with no artifacts. The theory behind 
this is that the EMG artifacts present in the ECG signal are equal to the EMG signals 
acquired from elsewhere in the body, thus by subtraction, the EMG portions can be 
eliminated. As this may not be entirely true, further conditioning of the EMG signal may 
be required to provide for a more robust system capable of isolating the ECG signal.  
 
10.4 Software 
The following recommendations detail further improvements that could be implemented 
within the software section of this project. Furthermore, the recommendations contained 
within this section do not have an overall affect towards the actual functionality of the 
device. The improvements will improve either the user interface or functionality of the 
device. The lack of implementation of any of the given improvements will not prevent 
the software portion of the project from operating.  
 
10.4.1 Signal Discrimination 
The assumptions made with regards to this project were that all physiological signals 
received by the system were not irregular rhythms. This is due to the fact that the HRV 
indices are specified as being the variations between normal to normal heart beats. 
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Depending on the type of irregular heart beat, the system is incapable of detecting and 
compensating for the anomaly.  
 
A further improvement should enable the program to detect whether the system is or is 
not receiving a normal sinus rhythm. When it has been detected that the heart rhythm is 
irregular, the program will then have to be further designed to disregard any peak-to-peak 
times. Therefore the system should be designed to be sufficiently robust that any 
anomalous rhythms and time intervals would be eliminated from the variability indices 
buffers, ensuring that no irregular time values are computed. As the normal-to-normal 
requirement for HRV calculations is true for both the ECG and PPG signals, the device 
should have the ability to determine whether this is true from either the ECG or PPG 
signals, such that the signals could reliably function independently.  
 
10.4.2 Threshold Reset Control 
The current design of the software program is to allow for the program to automatically 
reset itself should a fault be detected due to the timers running too long between peaks. 
This was implemented by using a simple comparison between the elapsed times of the 
timers and a constant set value. Should the elapsed times increase above 3 seconds, the 
system determines that a fault has occurred and attempts to correct for this by resetting 
the peak detection threshold. This is done due to the possibility that the system may not 
be capable of detecting peaks due to the threshold setting being set higher than the actual 
signal peaks. This may occur should there be a significant amount of signal artifact either 
from sensor movement or acquisition of anomalous signals. Should a significantly higher 
peak value enter the automatic threshold adjuster, shown in Section 6.3.3.1, the calibrated 
threshold may become sufficiently high to prevent the detection of further peaks.  
 
The current design of the automatic reset controls are that they are dependent on the 
elapsed timers going above a constant value of 3 seconds. As such, after having reset the 
threshold, once a peak has been detected, the reset function is disabled. Should this occur 
when the anomalous signal peak is still contained within the threshold adjuster buffer, 
shown in Figure 6.17 and Figure 6.18, the system will continue to be unable to detect 
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signal peaks unless the threshold is reset. Utilizing a buffer size of 5 points, and a fault 
detection of 3 seconds, should an anomalous signal peak enter the buffer, it will take a 
minimum of 15 seconds for the system to recover. Future improvements should work to 
determine which of the two signals are faulting, and to create a more robust system for 
resetting the thresholds. Possible methods for improvement involve resetting all points 
within the buffer to the threshold reset value, eliminating any problematic values. A 
second method of improvement involves a system to hold the reset value once activated, 
allowing new signal peaks to replace the anomalous signal peak contained within the 
adjustment buffer.  
 
10.4.3 Microcontroller Development 
A final development for the software portion of this project would be to implement the 
LabVIEW software into a self-contained unit. This would involve the use of an 
embedded microcontroller to perform the necessary functions of the software analysis 
and the eventual display of the signals and calculated indices. For use with this section, 
the current designs for the PPG and ECG hardware sensor suites could be retained, 
necessitating a replacement of the software portions of the project.  
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Glossary 
Glossary terms courtesy of Merriam-Webster OnLine 
 
Cardiac Arrest (CA): Abrupt temporary or permanent cessation of the heartbeat 
(as from ventricular fibrillation or asystole) -- called also sudden cardiac arrest 
 
Congestive Heart Failure (CHF): Heart failure in which the heart is unable to 
maintain adequate circulation of blood in the tissues of the body or to pump out 
the venous blood returned to it by the venous circulation 
 
Coronary Artery Disease (CAD): A condition and especially one caused by 
atherosclerosis that reduces the blood flow through the coronary arteries to the 
heart muscle and typically results in chest pain or heart damage -- called also 
coronary disease, coronary heart disease 
 
Diastole: The passive rhythmical expansion or dilation of the cavities of the heart 
during which they fill with blood 
 
Dicrotic Notch: A secondary upstroke in the descending part of a pulse tracing 
corresponding to the transient increase in aortic pressure upon closure of the aortic 
valve -- called also dicrotic wave 
 
Dyspareunia: Difficult or painful sexual intercourse 
 
Elastin: A protein that is the chief constituent of elastic fibers 
 
Esophagus: A muscular tube that in adult humans is about nine inches (23 
centimeters) long and passes from the pharynx down the neck between the trachea 
and the spinal column and behind the left bronchus where it pierces the diaphragm 
slightly to the left of the middle line and joins the cardiac end of the stomach 
 
Hemoglobin (Hb): An iron-containing respiratory pigment of vertebrate red blood 
cells that functions primarily in the transport of oxygen from the lungs to the 
tissues of the body 
 
HRV (HRV): Variability of inter-beat intervals of the HR 
 
NI: National Instruments; developer of the LabVIEW software suite.  
 
Parasympathetic Nervous System (PNS): The part of the autonomic nervous system 
that contains chiefly cholinergic fibers, that tends to induce secretion, to increase 
the tone and contractility of smooth muscle, and to slow the HR 
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Premature Ventricular Contraction (PVC): Contraction of the left and right ventricles 
prior to depolarization of the atria 
 
Saturation Pressure of Oxygen (Sp02): Partial pressure of oxygen present in arterial 
blood 
 
subVI: Instance of a LabVIEW Virtual Instrument contained within a higher level 
Virtual Instrument 
 
Stroke Volume: The volume of blood pumped from a ventricle of the heart in one 
beat 
 
Sympathetic Nervous System (SNS): The part of the autonomic nervous system that 
is concerned especially with preparing the body to react to situations of stress or 
emergency, that contains chiefly adrenergic fibers and tends to depress secretion, 
decrease the tone and contractility of smooth muscle, increase HR 
 
Systole: The contraction of the heart by which the blood is forced onward and the 
circulation kept up 
 
P Wave: A deflection in an electrocardiographic tracing that represents atrial 
depolarization of the heart 
 
QRS Complex: A deflection in an electrocardiographic tracing that represents 
ventricle depolarization of the heart 
 
T Wave: A deflection in an electrocardiographic tracing that represents ventricle 
repolarization of the heart 
 
VI: Virtual Instrument; a LabVIEW program consisting of a front panel control 
and a functional block diagram 
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HRV Monitor 
 
 
Figure A.1: LabVIEW front panel 
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Figure A.2: LabVIEW block diagram 
 148 
 
 
 
DAQ Assistant 
DAQ Assistant 
Creates, edits, and runs tasks using NI-DAQmx. Refer to the DAQ Quick Start Guide for 
information on devices supported by NI-DAQmx. 
 
When you place this Express VI on the block diagram, the DAQ Assistant launches to create a 
new task. After you create a task, you can double-click the DAQ Assistant Express VI in order to 
edit that task. For continuous measurement or generation, place a loop around the DAQ Assistant 
Express VI.  
 
For continuous single-point input or output, the DAQ Assistant Express VI might not provide 
satisfactory performance. Refer to examples\DAQmx\Analog In\Measure Voltage.llb\Cont 
Acq&Graph Voltage-Single Point Optimization for techniques to create higher-performance, 
single-point I/O applications. 
 
 
 
PPG Select 
Select Signals 
Accepts multiple signals as inputs and returns only the signals you select. You can specify which 
signals to include in the output and change the order of the input signals. 
-------------------- 
 
This Express VI is configured as follows: 
 
Selected Signals:    1,  
 
 
 
PPG Filter 
Filter 
Processes signals through filters and windows. 
-------------------- 
 
This Express VI is configured as follows: 
 
Filter Type: Band-pass 
Upper Cut-Off: 6 
Lower Cut-Off: 0.8 
IIR/FIR: Infinite Impulse Response (IIR) Filter 
Topology: Butterworth 
Order: 4 
 
 
 
ECG Select 
Select Signals 
Accepts multiple signals as inputs and returns only the signals you select. You can specify which 
signals to include in the output and change the order of the input signals. 
-------------------- 
 
This Express VI is configured as follows: 
 
Selected Signals:    0,  
 
 
 
ECG Filter 
Filter 
Processes signals through filters and windows. 
-------------------- 
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This Express VI is configured as follows: 
 
Filter Type: Band-pass 
Upper Cut-Off: 35 
Lower Cut-Off: 1 
IIR/FIR: Infinite Impulse Response (IIR) Filter 
Topology: Butterworth 
Order: 3 
 
 
 
Convert from Dynamic Data 
Convert from Dynamic Data 
Converts the dynamic data type to numeric, Boolean, waveform, and array data types for use with 
other VIs and functions. 
 
 
 
Differential 
Time Domain Math 
Performs one of several math functions on time domain signals. 
-------------------- 
 
This Express VI is configured as follows: 
 
Math Operation:  Differential 
Calculation Mode:  Continuous Calculation 
 
 
 
Timer 
Elapsed Time 
Indicates the amount of time that has elapsed since the specified start time. 
-------------------- 
 
This Express VI is configured as follows: 
 
Time Target: 1 s 
Auto Reset: Off 
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Threshold Adjust ECG 
 
 
 
 
Figure A.3: ECG threshold adjust control front panel 
 
 
Figure A.4: ECG threshold adjust control block diagram 
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Threshold Adjust PPG 
 
 
 
 
Figure A.5: PPG threshold adjust control front panel 
 
 
Figure A.6: PPG threshold adjust control block diagram 
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Signal Conditioning ECG 
 
 
 
 
Figure A.7: ECG signal conditioning front panel 
 
 
Figure A.8: ECG signal conditioning block diagram 
 
 153 
Signal Conditioning PPG 
 
 
 
 
 
Figure A.9: PPG signal conditioning front panel 
 
 
Figure A.10: PPG signal conditioning block diagram 
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Analyze ECG 
 
 
 
 
Figure A.11: ECG signal analysis front panel 
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Figure A.12: ECG signal analysis block diagram with 8-beat HR average 
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Figure A.13: ECG 5-beat  HR average 
 
 
Figure A.14: ECG instantaneous HR 
 
Analyze PPG 
 
 
 
 
Figure A.15: PPG signal analysis front panel 
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Figure A.16: PPG signal analysis with 8-beat PR average 
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Figure A.17: PPG with 5-beat PR average 
 
 
Figure A.18: PPG instantaneous PR 
 
ECG Beep 
 
 
 
 
Figure A.19: ECG audible beep front panel 
 
 
Figure A.20: ECG audible beep block diagram 
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Fault 
 
 
 
 
Figure A.21: Signal fault analsis front panel 
 
 
Figure A.22: Signal fault analysis block diagram 
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Record 
 
 
 
 
Figure A.23: Signal recording front panel 
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Figure A.24: Signal recording block diagram 
 
 
 
Waveform File Name 
Prompt User for Input 
Displays a standard dialog box that prompts users to enter information, such as a user name and 
password. 
-------------------- 
 
This Express VI is configured as follows: 
 
Message to Display to the User:Please specify file name for recorded waveform data 
The inputs are:  
Text Entry Box: Name 
 
 
 
Build Text 
Build Text 
Creates an output string from a combination of text and parameterized inputs. If the input is not a 
string, this Express VI converts the input into a string based on the configuration of the Express 
VI. 
-------------------- 
 
This Express VI is configured as follows: 
 
Text with parameters:  %Path%%Name%%Type% 
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Alarm 
 
 
 
 
Figure A.25: Alarm control front panel 
 
 
Figure A.26: Alarm control block diagram showing dual analysis 
 
 
Figure A.27: Alarm control for HR analysis 
 
 
Figure A.28: Alarm control for PR analysis 
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ECG Circuit Design 
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Figure B.1: ECG Circuit Revision A 
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Figure B.2: ECG Circuit Revision B 
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Figure B.3: ECG Circuit Revision C 
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PPG Transimpedance Amplifier Circuit 
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Figure B.4: Simple transimpedance amplifier 
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Figure B.5: Differential transimpedance amplifier 
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PPG Circuit Design 
 
Figure B.6: PPG circuit schematic 
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Figure B.7: Printed circuit board schematic 
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Figure B.8: Hardware case specifications 
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Printed Circuit Board 
 
 
Figure B.9: Printed circuit board images 
 
Visual Assembly 
 
 
Figure B.10: Hardware assemply images 
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External Hardware Views 
  
 
  
 
 
Figure B.11: Exterior hardware views 
Isometric 
Isometric Back 
Front 
Left 
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Appendix C. Bill of Materials 
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Table C.1: Bill of Materials 
Component Quantity Cost per Unit Total Cost 
Resistor – 15 K 3 0.1 0.3 
Resistor – 30 K 3 0.1 0.3 
Resistor – 20 K 2 0.1 0.2 
Resistor – 100 K 2 0.1 0.2 
Resistor – 75 K 1 0.1 0.1 
Resistor – 12 K 2 0.1 0.2 
Resistor – 150 K 1 0.1 0.1 
Resistor – 560 K 1 0.1 0.1 
Resistor – 510 1 0.1 0.1 
Resistor – 5.1 M 1 0.1 0.1 
Resistor – 120 K 1 0.1 0.1 
Resistor – 24 K 1 0.1 0.1 
Resistor – 3K 1 0.1 0.1 
Resistor – 160 K 3 0.1 0.3 
Resistor – 2.7 K 1 0.1 0.1 
Capacitor – 0.1 μF 5 0.25 1.25 
Capacitor – 0.01 μF 1 0.25 0.25 
Capacitor – 10 μF 2 0.25 0.5 
Diode 1 0.1 0.1 
PPG LED 1 0.3 0.3 
PPG Photodiode 1 0.74 0.74 
IC Socket – 8 Pin 3 0.29 0.87 
IC Socket – 14 Pin 2 0.29 0.58 
LM348N 2 0.5 1 
LM741 1 0.5 0.5 
LM555 1 0.5 0.5 
LF398 1 0.5 0.5 
Printed Circuit Board 1 35.83 35.83 
DB9 Connector 1 1.99 1.99 
ECG Connector Block 1 1.45 1.45 
Forehead Sensor 1 5 5 
ECG Electrodes/leads 1 N/A   
Device Case 1 5.8 5.8 
Rubber Support Feet 4 2.49 9.96 
Switch 1 2.34 2.34 
BNC Connectors 2 1.99 3.98 
Battery – 9V 2 3.99 7.98 
Total Device Cost 83.82 
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Appendix D. Component Specifications 
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Table D.1: Component Value Listing 
Component Value 
R1 15 KΩ 
R2 30 KΩ 
R3 30 KΩ 
R4 20 KΩ 
R5 20 KΩ 
R6 100 KΩ 
R7 100 KΩ 
R8 15 KΩ 
R9 75 KΩ 
R10 12 KΩ 
R11 150 KΩ 
R12 560 KΩ 
R13 510 Ω 
R14 5.1 MΩ 
R15 30 KΩ 
R16 120 KΩ 
R17 24 KΩ 
R18 3 KΩ 
R19 160 KΩ 
R20 2.7 KΩ 
R21 160 KΩ 
R22 160 KΩ 
R23 12 KΩ 
R24 15 KΩ 
C1 10 uF 
C2 0.01 uF 
C3 0.1 uF 
C4 0.1 uF 
C5 10 uF 
C6 0.1 uF 
C7 0.1 uF 
C8 0.1 uF 
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Appendix E. User’s Manual 
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Device Description 
 PC-Based Dual Channel HRV/PRV Monitor 
Hardware Suite 
 Dimensions: 4.31x3.06x1.37 inches 
 Weight: 8.1 oz (not including sensor probe and electrode leads) 
 Color: Black 
 Power: Two 9V batteries 
Accessories 
 3-lead electrodes 
 Forehead PPG sensor 
 CD: HRV Assist 
 User manual 
System Requirements 
 NI Data Acquisition Board 
 LabVIEW 8 or higher 
Patient Range 
 Adult 
Performance Specifications 
 Waveform Displays 
 Alarm indicator 
 High and Low Alarm controls  
 QRS beep and alarm sound 
 HR/PR Averaging: Instantaneous, 5-beat, 8-beat averaging 
 HRV/PRV Averaging buffer: 30 seconds, 1 minute, 5 minutes 
ECG 
 Input: 3-lead: RA; LA; LL or R; L; F 
 Lead selection: Lead IIECG waveform: 1 channel 
 Bandwidth: 0.05-35Hz 
 HR range: Adult: 15-240bpm 
 Accuracy: ±1bpm or ±1%, whichever is greater 
 Alarm range: Adult: 15-240bpm 
 QRS indicator: Audible 
PPG 
 Input: Forehead sensor 
 Sensor mode: Reflectance (IR wavelength only) 
 PPG waveform: 1 channel 
 Bandwidth: 0.05-10Hz 
 PR range: Adult: 30-240bpm 
 Accuracy: ±1bpm, @ 30 - 120 bpm during rest 
 Alarm range: Adult: 15-240bpm 
Software  
 Adjustable Threshold Peak detection 
 Abnormal R-R Interval Rejection 
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PPG Sensor Suite 
 
 
Figure E.1: PPG sensor suite 
 
ECG Electrode Leads 
 
 
Figure E.2: ECG electrode leads 
Electrode Connectors 
Hardware Input 
Connector  
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Hardware Suite 
 
 
 
 
 
Figure E.3: Hardware suite with labels 
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Software: HRV Assist 
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Figure E.4: Software front panel with labels 
 
A Start Data Acquisition L PR display 
B ECG Signal display M PPG SDNN display 
C PPG Signal display N PPG rMSSD display 
D Stop button O PRV Buffer Indicator 
E High alarm control P Recording Time Elapsed 
F Low alarm control Q Manual Threshold Reset and LED indicator 
G Alarm LED R Start Data Analysis and LED indicator 
H HR display S Beep Mute Switch and indicator 
I ECG SDNN display T HR/PR averaging control 
J ECG rMSSD display U HRV/PRV Buffer Size control 
K HRV Buffer Indicator V Alarm setting control 
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PPG Sensor Application 
1. Clean the PPG sensor site with alcohol to remove any skin oils. See shaded illustration below for 
the recommended site. 
 
 
 
2. Fasten elastic band around head, placing LED /Photodiode arrangement being placed directly over 
cleaned area. Avoid hair covering the diode unit. Fasten to ensure close contacts between sensor 
and skin. 
3. Plug in the PPG sensor into the DB9 connector of the hardware unit. 
 
 
 
4. Plug in BNC connector labeled PPG to AN1 of the DAQ Assist 
 
 
 
 
ECG Sensor Application 
1. Clean the ECG electrode site with alcohol to remove any skin oils. See shaded illustration below 
for the recommended site. 
2. Place adhesive electrode over cleaned area 
3. Snap electrode lead connectors unto electrode with the following 
 
a. Red: Ground (Gnd) 
b. Brown contact with blue wire: Right Arm (RA) 
c. White contact with blue wire: Left torso (LL) 
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4. Plug in the tri-electrode lead wire to the electrode connector of the hardware unit. 
 
 
 
 
5. Plug in BNC connector labeled ECG to AN0 of the DAQ Assist. 
 
 
 
 
To start signal acquisition 
1. Adjust patient properly in front of computer. 
2. Open LabVIEW VI labeled “HRV.exe” 
 
 182 
 
 
3. Enter HR alarm range in the controls labeled HIGH AND LOW ALARMS. Default values are 150 
and 45 BPM respectively. 
4. Configure the following parameters from the following options as desired: 
 
 
Control Description Options 
HR Averaging 
Controls the number of beats used 
to compute the HR/PR. 
Instantaneous HR 
5-beat Average 
8-beat Average (Default) 
HRV Buffer Size 
Controls window size to compute 
HRV and PRV  indices 
30 seconds 
1 minute 
5 minutes (Default) 
Alarm Monitor Setting 
Controls which signals to trigger 
alarm off its high or low values 
ECG Signal 
PPG Signal 
Both (Default) 
 
5. When patient is ready, turn on the switch on the hardware. 
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6. To start data acquisition, click on the arrow key ( ) labeled below. 
 
 
 
7. This will prompt a dialog box named SELECT A FILE TO SAVE. Enter desired file name and 
save location, then click OK. 
Start Acquisition 
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8. You should ECG and PPG signals on the monitor, and hear heart beep sound. Beep sound can be 
turned off with the MUTE button. 
Note:  If signals do not display: 
 check that ECG and PPG are connected to inputs 0 and 1 respectively 
 check that ECG leads are properly attached using the specified colour code 
           If an unusual PPG waveform is observed, adjust PPG sensor till a proper signal is observed.  
           If no signals displayed after the above adjustments, replace device battery 
.  
9. To start signal analysis recording analysis, click the START button. The Start LED should turn 
ON. 
Note: HRV and PRV indices will not display till respective buffers (blue) are full. 
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10. If an abnormally high PR or HR is observed, click on the RESET button to reset threshold value. 
Deactivate, clicking on button when adjusted HR is observed.  
11. To stop data recording analysis, click the start button. The Start LED should turn OFF. Signals 
will still be observed. 
12. To stop data acquisition, click on the blue STOP button. 
 
Start Data 
Analysis 
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Appendix F. Test Results 
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Figure F.1: PPG circuit test points 
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Table F.1: ECG elapsed time error analysis 
30 BPM 60 BPM 120 BPM 240 BPM 
1.891 0.906 0.391 0.109 
1.906 0.906 0.406 0.203 
1.891 0.891 0.406 0.109 
1.907 0.891 0.391 0.203 
1.891 0.891 0.406 0.109 
1.891 0.906 0.406 0.203 
1.907 0.906 0.406 0.109 
1.907 0.906 0.406 0.203 
Expected (Seconds) 
2 1 0.5 0.25 
Averaged Error (Seconds) 
0.101125 0.099625 0.09775 0.094 
 
Table F.2: PPG elapsed time error analysis 
30 BPM 60 BPM 120 BPM 240 BPM 
1.89 0.89 0.407 0.203 
1.89 0.89 0.407 0.109 
1.89 0.906 0.407 0.203 
1.906 0.89 0.407 0.109 
1.797 0.89 0.407 0.203 
1.906 0.89 0.407 0.109 
1.906 0.906 0.407 0.203 
1.703 0.89 0.407 0.109 
Expected (Seconds) 
2 1 0.5 0.25 
Averaged Error (Seconds) 
0.139 0.106 0.093 0.094 
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Figure F.2: ECG/PPG elapsed time error analysis 
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Table F.3: Signal comparison with motion artifact 
 Moderate Intensity High Intensity 
Rest 95.50 93.95 84.20 83.68 
 7.41 7.74 4.15 4.77 
Upper Body Motion 101.79 91.49 88.72 89.61 
 18.12 21.14 7.24 8.02 
Lower Body Motion 100.34 100.25 93.44 92.10 
 8.82 10.89 7.56 35.45 
Lateral Head Motion 91.97 91.35 95.61 93.20 
 4.74 15.15 5.81 7.28 
Up-Down Head Motion 89.37 85.97 90.43 91.09 
 4.41 12.82 5.24 8.36 
Fast Breathing 94.35 95.99 85.68 87.44 
 4.04 12.04 7.77 7.00 
Slow Breathing 100.72 102.19 90.81 89.75 
 9.52 13.72 5.18 6.34 
 
 
Figure F.3: Stainless steel electrodes 
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Figure F.4: Ag/AgCl electrode without adhesive 
 
 
Figure F.5: Ag/AgCl electrode with adhesive 
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Appendix G. Industry Product Specifications 
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Table G.1: Dual channel ECG/PPG monitor 
 Mindray PM 7000 Vitalmax 4100CL DINAMAP Pro 100 
Display type Color Color Color 
ECG 
Input 
5 lead 
3 lead 
 
3 lead 3 lead 
HR range 
 
Adult: 15-300bpm 
Pediatric/neonatal: 
15-350bpm 
30-254bpm 30-300bpm 
Heart rage averaging  4 beat average  
Accuracy ±1bpm or ±1% ±5bpm or 10% ±3bpm 
Bandwidth 0.05-100Hz 0.5-40Hz 0.5-40Hz 
Alarm Yes  Yes  Yes  
PPG 
Sensor type 
Mindray SpO2 , 
Masimo SET  SpO2, 
Nellcor  SpO2 
Finger, universal, 
earlobe clip, 
disposable and 
reusable wrap probe 
Nellcor, Masimo SET 
SpO2 
PR range 0-254bpm 30-254bpm 25-250bpm 
PR averaging  8 second averaging  
Accuracy ±2bpm ±2% at 30-100bpm ±3 digits 
 
Table G.2: Portable pulse oximeter sensor battery life 
Model Battery Life 
Nonin PalmSAT® 2500 100 hrs : 45 hours from rechargeable batteries 
Nellcor OxiMax
®
 N-65
™
 19 or 40 hours depending on battery type 
Nellcor N-20PA 32 hours 
Mindray PM-60 36 hours 
Mindray VS-800 10 hours 
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Figure G.1: Industry forehead PPG sensor 
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Marquette Medical Systems 8500 Series Holter Monitor 
Table G.3: Marquette Medical Systems Holter Monitor 
Length Width Height Weight 
6.0 inches 3.25 inches 1.125 inches ~10 oz 
 
 
Figure G.2: Marquette Medical Systems holter monitor 
 
 
Figure G.3: Internal view of Marquette holter monitor 
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Appendix H. Physiological Information 
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Figure H.1: Anatomic references of perfusion measurements 
Figure courtesy of E. Tur et al [59] 
 
 
Figure H.2: Ranking of perfusion measurements 
Figure courtesy of E. Tur et al [59] 
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Figure H.3: Einthoven's triangle [9] 
 
 
Figure H.4: ECG Electrode placements [12] 
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